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The neuropeptide substance P (SP) has been identified as a key pro-
inflammatory mediator in experimental acute pancreatitis (AP). SP is a product of the 
preprotachykinin-A (PPTA) gene, and it binds mainly to neurokinin-1 receptor 
(NK1R). SP and NK1R were previously detected in isolated pancreatic acinar cells, 
and up-regulation of pancreatic SP/NK1R was observed upon induction of AP in 
mice. Despite this knowledge, mechanisms that regulate the expression of SP and 
NK1R in AP remain elusive. In this thesis, possible mechanisms that caused 
SP/NK1R up-regulation after induction of AP were examined using both in vitro and 
in vivo murine models of AP.   
The effect of caerulein, a cholecystokinin analogue, on SP/NK1R expression 
in isolated pancreatic acinar cells was first investigated. In these cells, both gene and 
protein expression of SP/NK1R responded to supraphysiological concentrations of 
caerulein (10
-7
M). The effect of caerulein on SP up-regulation could be blocked by 
pre-treatment of a CCKA receptor antagonist, devazepide.  Caerulein also induced the 
phosphorylation of several downstream signaling kinases, which include PKC, 
PKC, ERK1/2 and JNK. Caerulein also induced DNA-binding activity of 
transcription factors AP-1 and NF-B. With the use of specific signaling molecule 
inhibitors, we identified that caerulein up-regulated the expression of SP/NK1R via a 
PKCα/PKC – JNK/ERK1/2 – NF-B/AP-1 dependent pathway.   
Apart from caerulein, it was found that activation of NK1R by SP (10
-6
M) or 
GR73,632, a selective NK1R agonist, significantly increased gene and protein 
expression of SP/NK1R in murine pancreatic acinar cells. These effects were 
abolished by pre-treatment of a selective NK1R antagonist, CP96,345. Pre-treatment 
 ix 
  
with specific inhibitors of PKC, PKC, ERK1/2, JNK and NF-B significantly 
inhibited SP-induced up-regulation of SP/NK1R. Therefore, activation of NK1R may 
up-regulate the expression of SP/NK1R through mechanisms similar to those induced 
by caerulein. The findings also suggest a possible auto-regulatory mechanism on 
SP/NK1R expression, which might contribute to elevated SP bioavailability.  
A third mechanism that explained increased SP levels was described using a 
mouse model of caerulein-induced AP. Caerulein suppressed neutral endopeptidase 
(NEP) activity and protein expression, which caused diminished degradation of SP. 
The role of NEP in AP was examined in two opposite ways. Further inhibition of 
NEP activity by pre-treatment with phosphoramidon or thiorphan raised SP levels, 
and exacerbated AP-induced inflammation in mice. Meanwhile, the severity of AP, 
determined by histological examination, tissue water content, myeloperoxidase 
activity and plasma amylase activity, was markedly decreased in mice that received 
exogenous NEP treatment. Our results suggest that NEP has a protective effect in AP, 
mainly by suppressing the pro-inflammatory activity of SP.  
In summary, the present study described three different mechanisms that 
might regulate the expression of SP and NK1R in caerulein-induced AP. Caerulein 
can directly up-regulate the expression of SP and NK1R through CCKA receptor– 
PKC/PKC - ERK/JNK- NF-B/AP-1 dependant pathway. Activation of NK1R 
also elevated SP/NK1R expression in murine pancreatic acinar cells, forming a 
positive feedback loop that enables further expression of SP/NK1R. Furthermore, a 
decrease in SP degradation, as shown by decreased NEP activity, may also contribute 
to elevated SP-NK1R interaction by increasing SP bioavailability.    
 x 
  
LIST OF TABLES 
 
Table 1.1 Evidence of SP-NK1R interaction in the pathogenesis of AP. ................... 21 
Table 2.1 PCR primer sequences, amplification cycles, annealing temperatures, and 
product sizes for semi-quantitative RT-PCR ............................................ 31 
Table 2.2 PCR primer sequences, amplification cycles, annealing temperatures, and 
product sizes for quantitative real-time PCR ............................................ 32 
Table 5.1 Effect of NEP inhibition on expression of cytokine, chemokine and 
adhesion molecules. ................................................................................ 132 
Table 5.2. Effect of NEP treatment on expression of cytokine, chemokine and 








LIST OF FIGURES 
 
Figure 1.1 Schematic illustration of the pathogenesis of AP. ....................................... 7 
Figure 2.1 RNA integrity was determined by the presence of distinct 28S and 18S 
rRNA bands. ............................................................................................. 30 
Figure 2.2 Caerulein induces PPTA mRNA expression, and also SP peptide 
expression in pancreatic acinar cells. ....................................................... 35 
Figure 2.3 Caerulein induces NK1R gene and protein expression in the pancreatic 
acinar cells. ............................................................................................... 37 
Figure 2.4 Caerulein induced SP up-regulation is mediated by CCKA signaling. ...... 39 
Figure 3.1 Caerulein treatment activates ERK and JNK in pancreatic acinar cells. ... 50 
Figure 3.2 PD98059 and SP600125 inhibited ERK and JNK activation respectively in 
pancreatic acinar cells. .............................................................................. 52 
Figure 3.3 The role of ERK and JNK pathways in mediating the increased expression 
of PPTA and SP. ....................................................................................... 54 
Figure 3.4 The role of ERK and JNK pathways in mediating the increased expression 
of NK1R. .................................................................................................. 55 
Figure 3.5 Caerulein induces AP-1 and NF-B activity in the pancreatic acinar cells.
 .................................................................................................................. 57 
Figure 3.6 ERK and JNK activation is involved in the DNA binding activity of NF-
B and AP-1. ............................................................................................ 59 
Figure 3.7 Bay 11-7082, a NF-B inhibitor, inhibited the expression of SP, PPTA and 
NK1R. ....................................................................................................... 61 
Figure 3.8 Caerulein induces phosphorylation of PKC and PKC in mouse 
pancreatic acinar cells ............................................................................... 63 
Figure 3.9 The effect of rottlerin and Gö6976 on PKC and PKC phosphorylation.
 .................................................................................................................. 66 
Figure 3.10 Caerulein stimulates PKC and PKC mediated SP gene and protein 
expression. ................................................................................................ 69 
 xii 
  
Figure 3.11 Caerulein stimulates PKC and PKC mediated NK1R gene and protein 
expression. ................................................................................................ 72 
Figure 3.12 The activation of ERK and JNK in mouse pancreatic acinar cells is 
dependent on both PKC and PKC. ....................................................... 75 
Figure 3.13 PKC and PKC activation is involved in the DNA binding activity of 
NF-B and AP-1. ...................................................................................... 77 
Figure 3.14 A schematic illustration of caerulein-induced up-regulation of SP in 
mouse pancreatic acinar cells. .................................................................. 87 
Figure 3.15 A schematic illustration of caerulein-induced up-regulation of NK1R in 
mouse pancreatic acinar cells. .................................................................. 88 
Figure 4.1 SP induced gene expression of PPTA and NK1R in murine pancreatic 
acinar cells. ............................................................................................... 94 
Figure 4.2 SP-induced, but not caerulein-induced PPTA/NK1R up-regulation is 
abolished by antagonism of NK1R. .......................................................... 97 
Figure 4.3 Activation of NK1R up-regulated SP peptide expression in isolated murine 
pancreatic acinar cells. .............................................................................. 99 
Figure 4.4 SP up-regulates NK1R protein expression in a time dependent manner. 100 
Figure 4.5 PKC, MAPK, and NF-B are involved in SP induced SP up-regulation in 
murine pancreatic acinar cells. ............................................................... 102 
Figure 4.6 PKC, MAPK, and NF-B are involved in SP induced NK1R up-regulation 
in murine pancreatic acinar cells. ........................................................... 103 
Figure 4.7 A schematic model summarizing the results of the chapter 4. ................. 110 
Figure 5.1 Administration of caerulein decreased NEP activity and expression in 
pancreatic acinar cells. ............................................................................ 119 
Figure 5.2 Administration of caerulein decreased NEP activity and expression in 
mice. ....................................................................................................... 122 
Figure 5.3 Inhibition of NEP by phosphoramidon and thiorphan decreased NEP 
activity and increased SP levels. ............................................................. 126 
Figure 5.4 Effect of NEP inhibition on plasma amylase activity, tissue MPO activity 
and tissue water content. ......................................................................... 129 
 xiii 
  
Figure 5.5 Histopathological  evaluat ion (H&E sta ining) of  pancreas 
polymorphonuclear leukocyte infiltration and injury. ............................ 130 
Figure 5.6 Effect of exogenous NEP on NEP activity and SP levels. ....................... 136 
Figure 5.7 Effect of exogenous NEP on plasma amylase activity, tissue MPO activity 
and tissue water content. ......................................................................... 139 
Figure 5.8 Effect of NEP on mRNA expression of NEP, NK1R and PPTA in the 
pancreas. ................................................................................................. 145 
Figure 6.1 Schematic representation of proposed mechanisms that regulate SP/NK1R 







AP Acute pancreatitis 
AP-1 Activator protein-1 
BSA Bovine serum albumin 
Cae Caerulein 
CCK Cholecystokinin 
cDNA Complementary deoxyribose nucleic acid 
DMSO  Dimethyl sulfoxide 
ELISA Enzyme-linked immunosorbent assay 
ERK Extracellular signal regulated kinase 
GPCR G-protein-coupled receptor 
HEPES N-2-hydroxyethylpiperazine-N’-2- ethanesulfonic acid 
HPRT Hypoxantine-guanine phosphoribosyl transferase 
ICAM Intracellular adhesion molecule 
IL- Interleukin 
IB I kappa B 
i.p. Intraperitoneal 
i.v. Intravenous 
JNK c-Jun N-terminal kinase 
MAPK Mitogen activated protein kinase  
MCP Monocyte chemoattractant protein 
MEK Mitogen-activated protein kinase Kinase 
MIP Macrophage inflammatory protein 
MPO Myeloperoxidase 
mRNA Messenger ribose nucleic acid 
NEP Neutral endopeptidase 
 xv 
  
NF-B Nuclear factor kappa B 
NK1R Neurokinin-1 receptor 
NKA Neurokinin A 
NKB Neurokinin B 
PBS Phosphate buffered saline 
PBST 0.05% Tween-20 in PBS 
PKC Protein kinase C 
PLC Phospholipase C 
PPTA Preprotachykinin-A gene 
PCR  Polymerase chain reaction 
RIPA Radio-immunoprecipitation assay 
SEM  Standard error of the mean 
SIRS Systemic inflammatory response syndrome 
SP Substance P 
TNF Tumor necrosis factor 
TRPV1 Transient receptor potential vanilloid 1 








1. Koh YH, Tamizhselvi R, Bhatia M. Extracellular signal-regulated kinase 1/2 and 
c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-
1, contribute to caerulein-induced expression of substance P and neurokinin-1 
receptors in pancreatic acinar cells. J Pharmacol Exp Ther. 2010; 332(3):940-8.   
2. Koh YH, Tamizhselvi R, Moochhala SM, Bian JS, Bhatia M. Role of Protein 
Kinase C in Caerulein Induced Expression of Substance P and Neurokinin-1-
Receptors in Murine Pancreatic Acinar Cells. J Cell Mol Med. 2011; 
15(10):2139-49. 
3. Koh YH, Moochhala SM, Bhatia M. Activation of Neurokinin-1 receptors Up-
regulates Substance P and Neurokinin-1 receptor in Murine Pancreatic Acinar 
Cells. J Cell Mol Med. 2011; doi: 10.1111/j.1582-4934.2011.01475.x. 
4. Koh YH. Moochhala SM, Bhatia M. The Role of Neutral Endopeptidase in 
Caerulein-Induced Acute Pancreatitis. J Immunol. 2011;187(10):5429-39. 
5. Tamizhselvi R, Sun J, Koh YH, Bhatia M. Effect of hydrogen sulfide on the 
phosphatidylinositol 3-kinase-protein kinase B pathway and on caerulein-
induced cytokine production in isolated mouse pancreatic acinar cells. J 
Pharmacol Exp Ther. 2009; 329(3):1166-77. 
6. Tamizhselvi R, Koh YH, Sun J, Zhang H, Bhatia M. Hydrogen sulfide induces 
ICAM-1 expression and neutrophil adhesion to caerulein-treated pancreatic 
acinar cells through NF-kappaB and Src-family kinases pathway. Exp Cell Res. 
2010; 316(9):1625-36. 
7. Hegde A, Koh YH, Moochhala SM, Bhatia M. Neurokinin-1 receptor antagonist 
treatment in polymicrobial sepsis: molecular insights. Int J Inflam. 2010; 
2010:601098. 
8. Tamizhselvi R, Shrivastava P, Koh YH, Zhang H, Bhatia M. Preprotachykinin-A 
gene deletion regulates hydrogen sulfide-induced toll-like receptor 4 signaling 
pathway in cerulein-treated pancreatic acinar cells. Pancreas. 2011; 40(3):444-52. 
Webpage reviews 
1. Koh YH, Bhatia M. (2011). Substance P (SP). The Pancreapedia: Exocrine 
Pancreas Knowledge Base, DOI: 10.3998/panc.2011.23  
International conference presentations 
1. Koh YH, Moochhala SM, Bian JS, Bhatia M. Protective effects of neutral 
endopeptidase in mouse model of caerulein-induced acute pancreatitis. The 3
rd
 
EMBO meeting, 2011, Vienna, Austria.   
 1 
  
CHAPTER 1 INTRODUCTION 
 
1.1 GENERAL OVERVIEW 
 
The pancreas is an oblong-shaped organ that has both endocrine and exocrine 
functions. The function of endocrine pancreas is well known, as it is responsible for 
secreting vital hormones such as insulin, glucagon and somatostatin, which regulate 
blood sugar and appetite. Irregularities of the endocrine pancreas’ function are 
associated with diabetes and blood sugar disorders. Endocrine pancreas consists of 
Islets of Langerhans, and is interspersed throughout the pancreas, contributing to only 
2-3% of the total pancreatic mass (Brannon, 1990). On the other hand, the exocrine 
pancreas contains clusters of enzyme-producing cells called the pancreatic acinar cells. 
Pancreatic acinar cells, along with pancreatic duct cells and other minor exocrine-
related cell types, form up to more than 90% of the total pancreatic mass. Pancreatic 
acinar cells produce large amount of proteases, lipases and amylase that are secreted 
into the small intestine to aid digestion. These powerful digestive enzymes are 
produced by the pancreas as an inactive molecule called zymogens, and activated in 
the small intestine by enteropeptidases. These  digestive enzymes can damage tissue 
when activated. Therefore, in the pancreas, a number of inhibitors are responsible to 





1.2 ACUTE PANCREATITIS 
1.2.1 Etiology and epidemiology of acute pancreatitis 
Inflammation is an immunological response characterized by redness, 
swelling, heat, and pain localized to a tissue. A rapid and prominent increase in 
pancreatic inflammation is a hall-mark of acute pancreatitis (AP). A majority of AP 
cases can be attributed to gallstones and alcohol abuse, making up for more than 80% 
of total cases (Sakorafas and Tsiotou, 2000; Gullo et al., 2002). Other less 
encountered causes of AP include drug use, endoscopic retrograde cholangio-
pancreatography, hyperlipidemia, trauma, viral infection, and autoimmune diseases. 
Cigaratte smoke has also recently been idenfied as a risk factor of AP, and its effects 
may be synergistic with alcohol consumption (Alexandre et al., 2011). Despite better 
knowledge on the pathogenesis of AP, up to 10% of cases remain idiopathic. It is 
notable that although a number of situations can cause AP in humans, only a small 
fraction of patients with these predisposing factors develop the disease. There is no 
clear association between gender and the occurrence of AP.  
AP is a fairly common clinical disorder. In the United States, approximately 
210,000 patients seek treatment for AP annually, placing a huge burden of more than 
USD2.2 billion in hospitalization costs (Fagenholz et al., 2007). In this study, blacks 
and the elderly were reported to have a higher incidence rate of AP, while whites and 
Hispanics have a relatively lower risk (Fagenholz et al., 2007). In another Swedish 
study, the incidence was reported to be about 38 per 100,000, which is similar to the 
average of Americans (Appelros and Borgstrom, 1999). In recent years, the incidence 
rate continued to rise at a rapid rate, widely believed to be caused by increasingly 
fatty diet and increased alcohol consumption (Yadav and Lowenfels, 2006). The 
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incidence rate in Asian population is reportedly lower than in the western world, but a 
similar uptrend in incidence rate was also observed.   
 
 
1.2.2 Mild vs. severe acute pancreatitis 
 
Patients with AP are roughly divided into two categories, mild AP and severe 
AP. Mild AP usually consists of interstitial edematous pancreatitis, where damage is 
limited within the pancreas and requires minimal medical attention. Mild AP usually 
recovers within a week without further complications. On the other hand, a 
necrotizing pancreatitis usually results in a severe form of AP. The initial assault 
deteriorates into pancreatic necrosis and the exaggerated inflammation sometimes 
cause systemic complications, resulting in multi-organ injury and a much higher 
mortality rate than observed with mild disease. Regardless of the severity, there is no 
correlation between the different etiologies and the severity of AP.  
As the outcome differs greatly between mild AP and severe AP, effective 
identification of AP and differentiating the severity during point of admission is 
important in determining the treatment required. As there is no single biological 
marker that accurately diagnose AP, initial diagnosis is based on the presence of at 
least 2 or 3 features, which include abdominal pain, increased serum 
amylase/lipase/trypsin levels and imaging tests (Smotkin and Tenner, 2002). Amylase 
is normally produced in the pancreas and salivary glands, and is responsible for 
digesting carbohydrates. During acute pancreatic injury, plasma amylase levels may 
rise up to 10 times above the normal level, and recover to normal levels within a week. 
However, the use of serum amylase alone does not offer sufficient sensitivity and 
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specificity. A previous study reported that plasma amylase levels occasionally remain 
at basal levels even in severe AP (Orebaugh, 1994). Further, the levels of serum 
amylase or lipase do not correspond to disease severity (Lankisch et al., 1999).  
Detection of serum lipase levels are often used in conjunction with serum amylase 
levels for initial assessment of AP. This fat digesting enzyme is also produced in the 
pancreas and an injury to the pancreas acutely raises serum lipase levels and peaks 
within 24 hours. Serum lipase levels reportedly offers better selectivity and sensitivity 
than amylase levels (Orebaugh, 1994; Smith et al., 2005).  A serum trypsin level test 
is thought to be the most sensitive blood test for pancreatitis, although it is still not 
widely available and routinely used.  
Enzyme assays alone cannot accurately assess the severity or cause of AP. 
After initial diagnosis of AP using serum enzyme activity tests, a series of 
physiological parameters should be taken and assessed for severity. These include a 
complete blood count, measurement of blood glucose, C-reactive protein and calcium 
levels, determination of liver function (including bilirubin and liver enzymes). 
Furthermore, imaging methods such as magnetic resonance 
cholangiopancreatography and computed tomography scans are used to observe 
abnormalities in the abdomen. These collected parameters are then used to evaluate 
for severity using Ranson’s score (Ranson et al., 1974), Acute Physiology and 
Chronic Health Evaluation II (APACHE II) score (Larvin and McMahon, 1989), or 
modified Glasgow Coma score (Williams and Simms, 1999). Among these scoring 
systems, the APACHE II scoring system reportedly has a better prediction value for 
severe AP (Yeung et al., 2006; Gravante et al., 2009).  
In about 80% of cases, patients suffer mild pancreatic edema and local 
pancreatic inflammation.  Other cases, which consist of 20-30% of all patients in AP, 
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experience a severe attack with a high mortality rate. In recent years, medical 
advances in critical care and management of AP patients have resulted in an 
improvement of outcome of AP. Despite this, the mortality rate remained persistently 
high for severe AP patients.  
 
1.2.3 Pathophysiology of acute pancreatitis 
 
Despite well-recognized etiologies of AP, the molecular mechanisms involved 
in the pathogenesis of AP remains incompletely understood. It is now commonly 
believed that AP originates from an injury in enzyme secreting pancreatic acinar cells. 
Inactive pancreatic zymogens are produced in pancreatic acinar cells and then 
secreted and eventually activated by enteropeptidases in the duodenum and small 
intestine.  Abnormal activation of these digestive enzymes within the pancreas could 
cause a chain reaction that cause massive activation of zymogens within the pancreas, 
resulting in an injury to the organ and triggers a complex cascade of events (Bhatia et 
al., 2005; Hirota et al., 2006).  
Activation of trypsinogen by the lysosomal hydrolase cathepsin B is now held 
to be an initiating event in acute pancreatitis. Lysosomal dysfunction also occurs in 
acute pancreatitis and appears to reduce the intracellular degradation of activated 
proteases (Halangk et al., 2000). Trypsin is a powerful protease that hydrolyses the C-
terminal side of lysine or arginine residues in a peptide chain, except when either is 
followed by a proline residue. Trypsin is responsible for cleaving several other 
zymogens, which include pro-enzymes for phospholipase A2, chymotrypsin and 
elastase in pancreatic acinar cells. Phospholipase A2 and elastase are particularly 
harmful in terms of direct cell damage, as they are capable of breaking down the 
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cellular membranes and blood vessels respectively (Niederau et al., 1995). In addition, 
release of pancreatic lipase by injured cells causes lipolysis of adipocyte triglycerides, 
which ultimately exacerbates pancreatic damage (Navina et al., 2011). These 
powerful enzymes, when activated together, leads to auto-digestion of the pancreatic 
tissue and release of noxious products into the surrounding tissue and system (Grady 
et al., 1998; Gorelick and Otani, 1999).  A massive activation of digestive enzymes 
also overwhelm the inhibitory mechanisms that keep enzyme activity in check, 
causing a reaction that tilts towards more destruction (Gorelick and Otani, 1999).   
After the initial assault, the events within the pancreatic acinar cell follows an 
unpredictable path that either result in mild, local interstitial inflammation or severe 
necrosis. Pancreatic injury release chemokines that attract leukocytes, which in turn 
aggravates inflammation and further damage surrounding healthy tissue. Therefore, it 
is important to understand the factors and underlying mechanisms that determine the 




Figure 1.1 Schematic illustration of the pathogenesis of AP. An abnormal event 
causes activation of trypsin and subsequent activation of pancreatic digestive 
enzymes in pancreatic acinar cells. The resulting injury causes acute pancreatic 
inflammation.  In severe cases, the exaggerated inflammation causes systemic 
complications accompanied with a high mortality rate.   
 
 
1.2.4 Severe acute pancreatitis and pancreatitis associated distant organ injury 
 
 In severe AP, harmful substances such as activated pancreatic enzymes and 
reactive oxygen species can spill over to other organs through the cardiovascular 
system, causing systemic inflammation. Complications frequently manifest as 
necrosis and organ failure in the pulmonary system, cardiovascular system and renal 
system, but pancreatitis-associated lung injury is most commonly observed (Beger et 
al., 1997; Browne and Pitchumoni, 2006). Among these noxious substances released 
by pancreatic injury, elastase appeared to be one of the most detrimental substance 
responsible for lung damage (Day et al., 2005). The lungs contain an abundant 
amount of elastin, but the breakdown of elastins by elastase could severely affect 
pulmonary function. This leads to acute lung injury and eventually causes acute 
respiratory distress syndrome. In fact, decreased pulmonary function and early onset 
of pleural effusion is associated with a poor outcome of AP (Browne and Pitchumoni, 
2006). Acute renal failure may ensue secondary to cardiovascular collapse and 
hypotension, resulting in acute tubular necrosis. 
Most complications of AP resolve within the first two weeks of onset. If 
severe AP is not resolved within this period, secondary pancreatic infection by 
microbes may ensue. Bacterial infection of necrotic tissues is now known to have a 
very high rate of mortality, accounting for nearly 80 percent of deaths (Beger et al., 
1997). Bacteriologic analysis of necrotic tissue revealed a higher proportion of gram-
negative germs such as Escherichia coli, and also gram-positive bacteria and fungi 
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(Tsui et al., 2009). In such cases, bacterial infection causes excessive cytokine 
secretion into the bloodstream by infiltrating leukocytes, causing uncontrollable 
inflammation and sepsis.  
1.2.5 Experimental models of acute pancreatitis 
 
Despite medical advancements in the management of AP, there remains much 
to be understood about the underlying mechanisms of AP. Currently, studies of severe 
acute human pancreatitis can be performed only with restrictions and are tissue 
samples are relatively inaccessible. Therefore, experimental models of AP that 
resemble the human situation are important tools to help understand the disease and to 
devise better treatment options. To date, a variety of animal models have been 
developed to produce features that are similar to human AP cases.  
Animal models of AP can generally be divided into two categories: Invasive 
models, which require surgery on experimental animals, and non-invasive models. 
These models produce AP that range from mild edematous pancreatitis to severe 
necrotizing pancreatitis, and they have proven to be valuable models to help 
understand the pathogenesis of AP. 
1.2.5.1 Caerulein-induced acute pancreatitis 
Caerulein is a short peptide with an amino acid sequence of Pglu-Gln-Asp-
Tyr[SO3H]-Thr-Gly-Trp-Met-Asp-Phe-NH2. Originally isolated from the skin of an 
Australian frog (Anastasi et al., 1967), caerulein is a structural homolog of the 
endogenous hormone cholecystokinin (CCK). Caerulein/CCK is a ligand of 
cholecystokinin receptors CCKA and CCKB; where CCKA receptors are pre-
dominantly located in the gastrointestinal tract and CCKB receptors are primarily 
located in the central nervous system (Noble et al., 1999). The CCKA receptors were 
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further found to contain a high-affinity binding state and a low-affinity binding state 
for its ligand. Physiological concentrations of CCK/caerulein stimulate enzyme 
secretion from the pancreatic acinar cells via stimulation of high-affinity CCKA 
receptors (Dufresne et al., 2006). On the other hand, when a supraphysiological dose 
of CCK/caerulein is given to the animals, the activation of low-affinity CCKA 
receptors lead to a distinctly different downstream signaling mechanism which 
blocked enzyme secretion from the pancreatic acinar cells (Saluja et al., 1989; 
Dufresne et al., 2006). The inability to secrete activated zymogens out of the 
pancreatic acinar cells will raise intracellular protease activities to a critical level that 
ultimately causes auto-activation of digestive enzymes within these cells (Saluja et al., 
1985; Saito et al., 1987).  
This feature of caerulein-induced AP has similarities with current knowledge 
on the pathogenesis of AP, where an abnormal activation of trypsinogen in pancreatic 
acinar cells caused subsequent inflammatory responses.  Furthermore, treatment of 
animals with caerulein can induce many features that resemble clinical AP, which 
include hyperamylasemia, pancreatic edema, cellular necrosis, zymogen activation, 
and severe inflammation of the pancreas (Grady et al., 1998; Gorelick and Otani, 
1999). Caerulein-induced AP is also highly reproducible, and it has been successfully 
shown to induce pancreatitis in different animals such as mice (Bhatia et al., 1998), 
rats (Wisner and Renner, 1988), rabbits (Klar et al., 1994),  and dogs (Morita et al., 
1998). Its convenience, reproducibility, and its non-invasive nature of induction of 
pancreatitis have encouraged its popularity in studying the pathogenesis of AP.  
Animals that received caerulein treatment rapidly develop AP. Significant 
physiological changes occur rapidly within three hours after caerulein administration 
into animals, and the diseased state is most significant after twelve hours of infusion 
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(Lampel and Kern, 1977). Caerulein-induced AP also induces pulmonary damage in 
its later stages, which is useful to study pancreatitis-induced distant organ damage. 
The pancreas of caerulein-induced AP also exhibit similar histological presentations 
to those found in the early phase of AP in humans (Dabrowski et al., 1999). 
Interestingly, infusion of caerulein into animals for a prolonged period of time (>12 
hours) did not cause further inflammation. Instead, it was found that pancreatic edema 
is largely reabsorbed after a 24 hour treatment, and the pancreas remained in an 
indurated state (Lampel and Kern, 1977; Adler et al., 1979). Therefore, one major 
drawback of caerulein-induced AP is that this model does not cause severe AP. 
Several important features of severe AP, such as hemorrhage and saponification of 
the lipids or death were not observed in caerulein-induced AP models.  Finally, over 
stimulation of CCK receptors is not a recognized cause of human AP. Despite these 
drawbacks, caerulein-induced AP remains to be one of the most popular methods and 
the use of this method shaped the current knowledge of AP.  
1.2.5.2 Diet-induced acute pancreatitis 
Mice fed with a diet deficient in choline and supplemented with ethionine 
(CDE-diet) develop severe AP (Lombardi et al., 1975). The toxic effects of ethionine 
caused intraparenchymal activation of zymogens, and the toxic effects were greatly 
potentiated by a diet deficient in choline. Besides massive inflammation and cellular 
necrosis in the pancreas, diseased mice also develop injuries characterized by 
hemorrhage and fat necrosis throughout the peritoneal cavity (Lombardi et al., 1975). 
Therefore, this experimental model exhibits similar characteristics with human AP 
cases with acute hemorrhagic pancreatitis and fat necrosis. Interestingly, the outcome 
of CDE-diet model depends greatly on gender (Lombardi and Rao, 1975).  Female 
mice died within four to five days after being fed with a CDE-diet, but male mice 
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develop AP that has inconsistent severity and a much lowered mortality rate. 
Therefore in female mice, the CDE-diet induced AP model is a cheap, highly 
reproducible and non-invasive alternative to the milder caerulein-induced model, 
which is suitable for studying of hemorrhagic AP and mortality studies.  
1.2.5.3 Amino acid (L-arginine and L-ornithine) induced acute pancreatitis 
Arginine is essential for protein synthesis and L-arginine is one of the most 
common natural amino acids. It was first observed in 1984 that injection of excess 
arginine into rats caused pancreatic acinar cell injury, without affecting the Islet of 
Langerhans (Mizunuma et al., 1984). The exact mechanisms by which arginine 
initiates AP is still unclear, but the involvement of reactive oxygen species (Czako et 
al., 1998) and nitric oxide (Takacs et al., 2002) are potential mechanisms that lead to 
the progression of AP. This model of AP is characterized by acute pancreatic 
inflammation, pancreatic edema, infiltration of leukocytes and capillary dilatation. 
Mortality rate is relatively low, averaging 2.5% in rat models (Hegyi et al., 2004). 
Interestingly, it is possible to modify the severity of AP by changing the dose of 
arginine administered to the animals (Hegyi et al., 2004). Animals that receive a 
larger dose of arginine is used for studies on the mechanisms of severe AP, and a 
smaller dose of arginine causes mild AP that could be used to characterize the 
regenerative processes of AP. Long term administration of arginine was also 
performed to study the mechanisms of chronic pancreatitis (Weaver et al., 1994).  
Administration of excess L-ornithine to animals was also recently proposed to 
induce severe AP (Rakonczay et al., 2008a). L-ornithine is a metabolic product of L-
arginine and is physiologically produced as an intermediate molecule in the urea 
cycle. Similar to L-arginine induced AP, administration of exogenous L-ornithine to 
rats caused massive interstitial edema, apoptosis/necrosis of acinar cells and 
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infiltration of neutrophil granulocytes. It was reported that L-ornithine induced a 
more severe form of pancreatitis, when compared with L-arginine induced models 
(Rakonczay et al., 2008a). However, the underlying mechanisms that leads to this 
difference remains to be investigated.  
1.2.5.4 Pancreatic duct ligation induced acute pancreatitis 
Since gallstone obstruction of the pancreatic ducts is a major risk factor of AP, 
the pancreatic duct ligation model is perhaps one of the more clinically relevant 
model available for studying the pathogenesis of AP. Pancreatic duct ligation was 
successfully applied in opossums (Lerch et al., 1993), mice (Samuel et al.) and rats 
(Walker, 1987), with the opossums consistently produce a particularly severe form of 
AP. Pancreatic juices containing zymogens are normally secreted to the digestive 
tract through a common biliopancreatic channel. An obstruction of pancreatic outflow 
through pancreatic duct ligation causes accumulation of pancreatic zymogens within 
the pancreas. The end result is an auto-activation of zymogens that initiate pancreatic 
injury and inflammation. Despite the clinical relevance, the pancreatic duct ligation 
model is technically difficult to perform, and also yields inconsistent results in the 
mice and rat models.   
1.2.5.5 Alcohol-induced acute pancreatitis 
Although excessive alcohol consumption is a well known risk factor of AP, 
chronic alcohol feeding alone failed to induce AP in animal models (Schneider et al., 
2002). Prior sensitization or additional procedures is required to produce a significant 
alcohol-induced injury to the pancreas. When rats were co-treated with alcohol and 
CCK, these animals exhibited pathological changes that resemble AP (Pandol et al., 
2003). Alcohol-induced AP can also be triggered by direct infusion of ethanol into the 
pancreatic duct (Schneider et al., 2002). However, the invasive nature of this model 
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would result in pancreatic injury and contribute to AP. Because of these observations, 
ethanol was thought to sensitize the pancreas to injury and inflammatory responses, 
rather than being a triggering factor itself (Pandol et al., 2003). Ethanol-induced AP 
models exhibit pathological features that are common to all AP models, which 
include zymogen activation and decreased pancreatic blood flow (Schneider et al., 
2002). 
Since alcohol consumption is considered a major risk factor for AP, these 
models provided a valuable tool to investigate the pathogenesis of AP in a more 
clinical relevant way.   
1.2.5.6 Pancreatic duct infusion model 
Various compounds have been infused into the pancreatic duct to induce AP. 
Infusion of a bile salt, sodium taurocholate, is most commonly performed in such 
experiments (Aho et al., 1980; Wittel et al., 2008). This model requires invasive 
surgery of the animal, and then the bile salts are injected into the pancreatic duct via a 
retrograde manner. After retrograde infusion, a severe, rapidly evolving and lethal 
variety of acute hemorrhagic pancreatitis is formed. However, the pancreatic duct 
infusion model is technically challenging as extra care is required to maintain a 
standard degree of injection pressure and surgery quality.   
1.2.5.7 Concluding remarks 
There has been great progress on uncovering the underlying mechanisms that 
dictate the initiation, progression and recovery of AP by using these various animal 
models. However, none of the commonly used models exactly mimic the inciting 
event of human cases of pancreatitis. Nonetheless, the pathologic features of these 
models of AP are very similar.  
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In this study, we chose caerulein-induced AP as a model for a variety of 
reasons. Firstly, caerulein-induced AP produces pancreatic acinar cell changes and 
pulmonary injuries that resemble human AP cases. Furthermore, caerulein-induced 
AP is very reproducible and was considered non-invasive. Finally, caerulein-treated 
pancreatic acinar cells were widely recognized as a cellular model of AP. With other 
considerations such as costs and time, we believe that the use of caerulein-induced 
AP model could best achieve the aims of the proposed study.  
1.2.6 Pancreatic acinar cells as an in vitro model of acute pancreatitis 
 
Pancreatic acinar cells form the bulk of pancreatic mass, and they are 
responsible for synthesis, storage and secretion of digestive enzymes. Evidence from 
animal models of AP suggested that pancreatic injury originated from dysfunction of 
these enzyme producing cells. Premature activation of zymogens leads to massive 
inflammation that ensued. Thus, isolated pancreatic acinar cells are widely considered 
to be a valid model to investigate pathological changes in pancreatitis.   
Caerulein treated pancreatic acinar cells is one of the best characterized 
cellular models of AP. Both isolated pancreatic acinar cells and the pancreas respond 
similarly when treated with CCK or its analogue caerulein. A low dose of CCK 
stimulates enzyme secretion from the pancreatic acinar cells. On the other hand, 
stimulation of these isolated cells with a high concentration of CCK/caerulein causes 
pathological changes that resemble the responses observed in animal models of AP 
(Thrower et al., 2008). For example, a supramaximal concentration of caerulein (10
-
7
M) causes intra-acinar cell activation of trypsinogen and increased trypsin activity 
(Hofbauer et al., 1998). Besides being the initiation site of injury in pancreatitis, 
pancreatic acinar cells also express cytokines and chemokines which might play a 
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role in inflammation. Treatment of isolated pancreatic acinar cells with caerulein 
caused up-regulation of noxious products which include pro-inflammatory 
interleukins (IL-1, IL-6) and reactive oxygen species, which (Yu et al., 2002; Samuel 
et al., 2006). Therefore, the pancreatic acinar cells represent a well suited in vitro 
system to investigate the pathogenesis of AP and the underlying signaling 
mechanisms involved.  
Two sources of pancreatic acinar cells were being used to investigate the 
pathophysiology of AP. The pancreatic acinar cell tumoral cell line, AR42J cells, 
proliferate rapidly and produce digestive enzymes in a way similar to normal 
pancreatic acinar cells. However, the regulation of exocrine function is different due 
to mutations in this tumoral cell line (Christophe, 1994). On the other hand, 
pancreatic acinar cells could be obtained from collagenase dispersion of the pancreas. 
Due to significant difficulties in culturing isolated pancreatic acinar cells for a 








1.3 SUBSTANCE P 
 
Substance P (SP) is an undecapeptide with an amino acid sequence of Arg-
Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2. It was first isolated in 1931 by Ulf 
von Euler and John H. Gaddum, who described the “preparation P” as a substance 
that cause intestinal contraction and lowered blood pressure (US and Gaddum, 1931). 
However, it was 1971 when the amino acid sequence of SP was determined and the 
ligand successfully synthesized (Chang et al., 1971; Tregear et al., 1971). This 
breakthrough permitted a larger and more accurate research on the physiological 
functions of SP. Forty years has passed since the successful identification of SP, and 
it is now known to be an important molecule which is involved in a myriad of 
biological functions.   
1.3.1 Tachykinin family of peptides 
 
Since the successful identification of SP, subsequent research has identified 
several other peptides that share similarities with SP. This family of short peptides 
were named “tachykinins”, which consist of SP, neurokinin A (NKA) (Kangawa et al., 
1983; Nawa et al., 1984), neurokinin B (NKB) (Kanazawa et al., 1984; Kimura et al., 
1984), and two elongated forms of NKA, neuropeptide K (Tatemoto et al., 1985) and 
neuropeptide  (Kage et al., 1988). Within this family of peptides, the biological 
functions of SP were most extensively studied. Tachykinins are characterized by a 
common C-terminal sequence, Phe-X-Gly-Leu-Met-NH2, where X is either an 
aromatic or an aliphatic amino acid (Severini et al., 2002). Tachykinins are produced 
by three genes in mammals, namely preprotachykinin A (PPTA), preprotachykinin B 
(PPTB), and preprotachykinin C (PPTC). The preprotachykinin gene encodes long 
precursor proteins, which are then cleaved by proteases to yield smaller peptides. 
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Tachykinins are important neurotransmitters; therefore members of the tachykinin 
family were also known as neuropeptides. Tachykinins elicit a wide spectrum of 
physiological effects, with reports showed their implications on cardiovascular 
system, intestinal motility and secretions, respiratory system, urogenital tract, immune 
system, central nervous system, and nociception. In more recent reports, tachykinins 
were also reported to have significant effects on inflammation (Severini et al., 2002).  
1.3.2 Sources and distribution of SP 
 
SP is encoded by the PPTA gene. It is synthesized as a larger protein in the 
ribosomes, and then enzymatically converted to the much shorter but biologically 
active undecapeptide and stored (Hokfelt and Kuteeva, 2006). SP is highly expressed 
in the peripheral nervous system (Pickel et al., 1983) and central nervous system 
(McCarthy and Lawson, 1989), but also shown to be induced or expressed in other 
cell types such as monocytes (Ho et al., 1997), macrophages (Ho et al., 1997), 
lymphocytes (Lai et al., 1998), pancreatic acinar cells (Tamizhselvi et al., 2007), 
Leydig cells (Chiwakata et al., 1991) and various tumors (Esteban et al., 2009; 
Gonzalez-Moles et al., 2009). A number of studies indicate control plasma SP levels 
in humans fall in the range between 30pg/ml to 500pg/ml (Reynolds et al., 1988; Lee 
et al., 1997; Bondy et al., 2003). Neuronal sources, mainly non-myelinated C-fiber 
sensory nociceptive neurons, represent a primary source of SP release in the periphery. 
The stored SP is released from the nerve endings upon activation of transient receptor 
potential vanilloid 1 (TRPV1) located on the surface of these C-fibres. Although SP 
was widely known as a neurotransmitter, the role of SP in inflammation has gained 
attention in recent years. 
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1.3.3 Neurokinin-1 receptor (NK1R) 
 
The biological actions of tachykinins are mediated by three distinct G-protein 
coupled receptors (GPCRs), NK1R, NK2R and NK3R. SP binds with high affinity to 
NK1R. SP can also bind and activate NK2R and NK3R, albeit with much less affinity 
and its physiological effects were less understood. NK1R is expressed in all major 
organs in the body, including pancreas and lungs (O'Connor et al., 2004). Depending 
on the cell type used, activated NK1R can couple to downstream Gq/11, Gs and 
Go proteins (Nishimura et al., 1998; Roush and Kwatra, 1998), which in turn 
activates the phospholipase C (PLC) pathway or adenylate cyclase pathway. NK1R 
might also function as an auto-receptor, as SP was found to modulate its own release 
(Malcangio and Bowery, 1999; Holzer and Holzer-Petsche, 2001). This auto-
regulation feature may be important in the pathophysiology of inflammation, nerve 
injury or noxious stimuli.  
1.3.4 Pro-inflammatory effects of SP 
 
The role of SP on inflammatory diseases has now become clearer. As the 
primary sensory nerve endings are a major source of SP release, an inflammatory 
response evoked by SP is popularly termed “neurogenic inflammation”. SP-NK1R 
interaction was proposed as a major pro-inflammatory process and many studies have 
now shown that disruption of the SP-NK1R interaction helps reduce inflammation.  
SP has been shown to play an early and important role in the inflammatory 
cascade and promote excessive activation of inflammatory cells. SP can activate NF-
B, a transcription factor that is known to control expression of pro-inflammatory 
cytokines and chemokines (Lieb et al., 1997; Sun et al., 2008). In T-lymphocytes, 
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neutrophils and macrophages, SP up-regulated the expression of several cytokines 
that are well known pro-inflammatory mediators, including tumor necrosis factor-
alpha (TNF-) interleukin 1-beta (IL-1), interleukin 2 (IL-2) and interleukin 6 (IL-6) 
(Delgado et al., 2003). SP also up-regulated chemokine receptor expression in 
primary mouse neutrophils (Sun et al., 2008), which might increase neutrophil 
responsiveness to the noxious compounds released from an inflamed site. On the 
other hand, SP also causes plasma extravasation, which contributes to localized 
edema in inflamed tissues (Figini et al., 1997).  
Interestingly, elevated levels of both SP and NK1R were observed in 
inflammatory disease, which might increase SP-NK1R interaction and aggravate 
inflammation. An elevated expression of SP receptor binding sites has been observed 
in the inflamed colon of patients suffering from inflammatory bowel disease (Goode 
et al., 2000). Similarly, increased NK1R expression was observed in lymphoid 
aggregates, small blood vessels, and enteric neurons in Crohn’s disease and a 
bacteria-induced model of colitis (Mantyh et al., 1995; Mantyh et al., 1996).  On the 
other hand, elevated systemic SP levels have been reported in postoperative septic 
patients (Beer et al., 2002). In addition, infiltrating leukocytes and induced SP 
production in the inflamed site could also contribute to elevated SP levels in the local 
tissue during inflammation, thus representing a non-neuronal source of SP. 
1.3.5 SP in acute pancreatitis 
 
SP-NK1R interaction was shown to be a key mediator in the pathogenesis of 
experimental AP. The role of SP in AP and associated lung injury has been 
extensively studied. It was found that in wild type mice, SP and NK1R expression in 
the pancreas are both increased during caerulein-induced AP (Bhatia et al., 1998; Lau 
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and Bhatia, 2006). Genetic deletion of either NK1R or PPTA protected mice against 
experimental pancreatitis. This was demonstrated by a significant reduction of the 
magnitude of hyperamylasemia, neutrophil sequestration in the pancreas, and 
pancreatic acinar cell necrosis in NK1R
-/-
 mice and PPTA
-/-
 mice, when compared 
with their wild type controls. Moreover, pancreatitis associated lung injury was 
almost completely abolished when NK1R or PPTA were knocked out, as shown by 
reduced intrapulmonary sequestration of neutrophils and pulmonary microvascular 
permeability (Bhatia et al., 1998; Bhatia et al., 2003). Similar protective effects were 
also observed in CDE-diet induced hemorrhagic pancreatitis in NK1R
-/-
 mice (Maa et 
al., 2000a). These results showed that PPTA gene products, as well as NK1R, are 
critical pro-inflammatory mediators in AP and the associated lung injury. SP-NK1R 
interaction is also a determinant of inflammatory edema in acute interstitial 
pancreatitis (Maa et al., 2000b). Furthermore, mice treated with CP96,345, a specific 
NK1R antagonist, either prophylactically or therapeutically, were significantly 
protected against caerulein-induced AP (Lau et al., 2005). These results point to a key 
role of SP-NK1R interaction in AP and associated lung injury.  
Primary sensory neurons that innervate the tissues contain an abundance of 
neurotransmitters, including SP. TRPV1 channels located on these neurons, when 
activated, causes neuronal release of stored SP. It was demonstrated in vivo that 
capsazepine, a TRPV1 antagonist, significantly reduced inflammation and pancreatic 
injury in caerulein-induced AP (Nathan et al., 2001). On the other hand, activation of 
TRPV1 by capsaicin caused release of SP, and exaggerated caerulein-induced SP 
(Hutter et al., 2005). Pre-treatment of capsazepine or CP96,345 before administration 
of capsaicin showed reduced severity of SP, highlighting the importance of TRPV1 
and NK1R (Hutter et al., 2005). High doses of Resiniferatoxin caused disruption of 
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the celiac ganglion and inhibited SP release, and showed protective effects against 
caerulein-induced pancreatitis in rats (Noble et al., 2006).  
Besides pro-inflammatory effects of SP in AP, it also mediates nociception in 
animal models of AP. Induction of necrotizing pancreatitis by L-arginine caused a 
large increase in c-fos expressing spinal neurons, suggesting activation of nociceptive 
pathways. Intrathecal administration of SR140333, a specific NK1R antagonist, was 
shown to suppress pancreatitis pain (Wick et al., 2006). In another study, 
intraperitoneal injection of CP99,994, another specific NK1R antagonist, attenuated 
nociceptive behaviours in dibutyltin dichloride induced AP (Vera-Portocarrero and 
Westlund, 2004).  
Table 1.1 Evidence of SP-NK1R interaction in the pathogenesis of AP.  
 SP-NK1R 
interaction 
Severity of AP Reference 
PPTA gene knockout Decrease Decrease Bhatia et al., 2003 
NK1R gene knockout Decrease Decrease Bhatia et al., 1998 
Maa et al., 2000 
NK1R antagonist Decrease Decrease Lau et al., 2005 
TRPV1 antagonist Decrease Decrease Nathan et al., 2001 
TRPV1 agonist Increase Increase Hutter et al., 2005 
Disruption of celiac ganglion Decrease Decrease Noble et al., 2006 
 
1.3.6 Metabolism of SP 
 
Compared to the well known pro-inflammatory effects of SP, the mechanisms 
that terminate its effects were lesser known. SP-NK1R interaction could be reduced 
by blocking with NK1R antagonists, but also by reducing SP bioavailability. 
Degradation of SP is one of the mechanisms that reduce SP levels in the system. 
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Currently, a few enzymes were implicated in the metabolism of SP, which include 
neutral endopeptidase (NEP), angiotensin-converting enzyme (ACE), dipeptidyl 
aminopeptidase IV, prolyl endopeptidase, cathepsin-D and cathepsin E (Harrison and 
Geppetti, 2001). However, only NEP and ACE were more commonly reported in the 
metabolism of SP in vivo (Harrison and Geppetti, 2001).  
NEP, also known as enkephalinase, neprilysin, common acute lymphoblastic 
leukemia antigen (CALLA) or CD10, is a membrane-bound enzyme known to 
degrade a variety of short peptides in the extracellular fluid, including SP. NEP 
cleaves SP at Gln6-Phe7, Phe7-Phe8, and Gly9-Leu10, thereby preventing SP from 
binding to its receptor (Skidgel et al., 1984). NEP is also known to degrade amyloid 
beta, a protein that is best known as a molecule implicated in Alzheimer’s disease.  
NEP is capable of modulating inflammatory responses by degradation of SP. 
This is supported by studies showing that NEP knockout or inhibition potentiates 
inflammation, but was prevented by co-treatment with NK1R antagonists (Sturiale et 
al., 1999). On the other hand, administration of exogenous recombinant NEP to 
animals is protective against inflammatory disorders, such as intestinal inflammation 
and burns (Neely et al., 1996; Sturiale et al., 1999; Kirkwood et al., 2001). Current 
evidence supports that NEP plays an anti-inflammatory role.    
ACE is a circulating enzyme that is most widely known for its role in the 
renin-angiotensin system. ACE inhibitors lower plasma angiotensin II levels and is 
widely applied as an anti-hypertensive drug. In comparison, the physiological role of 
ACE on SP is poorly understood. Purified ACE was found to inactivate SP by 
cleaving it at Phe8-Gly9 and Gly9-Leu10 position (Skidgel et al., 1984). Inhibition of 
ACE by captopril or enalapril potentiated SP-induced bronchoconstriction in guinea 
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pigs (Subissi et al., 1990). ACE was also found to play a part in SP-induced 
inflammation. In a model of ACE-knockout mice, an increased SP level was observed 
and subject animals were more susceptible to cutaneous inflammatory responses to 
allergens (Scholzen et al., 2003). 
1.3.7 SP and NK1R in isolated pancreatic acinar cells 
 
Expression of SP and NK1R has been detected in isolated pancreatic acinar 
cells. Their expression can be rapidly induced by caerulein, but its physiological 
significance is unclear (Tamizhselvi et al., 2007). On the other hand, exogenous SP is 
able to stimulate the expression of chemokines in isolated primary pancreatic acinar 
cells. Exposure of mouse pancreatic acini to SP significantly increased synthesis of 
monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1 alpha 
(MIP-1), as well as macrophage inflammatory protein-2 (MIP-2). The stimulatory 
effect of SP was mediated through the NF-B pathway (Ramnath and Bhatia, 2006). 
SP, acting specifically through NK1R, induced the activation of protein kinase C- 
(PKC), ERK and JNK with a time-dependent manner in isolated pancreatic acinar 
cells (Ramnath et al., 2007; Ramnath et al., 2008). Inhibition of PKC, ERK or JNK 
with their respective specific inhibitors attenuated SP-induced chemokine production 
(Ramnath et al., 2007; Ramnath et al., 2008). More recently, a critical role of SRC 
family kinases (SFKs) has been demonstrated. SFKs mediated the activation of 
mitogen activated protein kinases (ERK, JNK), transcription factors (NF-B, AP-1, 
STAT3), and production of chemokines in pancreatic acinar cells (Ramnath et al., 
2009).  
Besides playing a role in pancreatic acinar cell gene expression, SP might also 
be involved in pancreatic secretory mechanisms. In isolated guinea pig pancreatic 
 24 
  
acinar cells, SP caused a twofold increase in amylase secretion (Patto et al., 1992). 
Experiments done on AR42J cells also showed evidence of increased exocrine 
secretion when these cells were treated with SP (Gorr and Tseng, 1995). On the other 
hand, SP inhibited bicarbonate secretion from guinea pig pancreatic ducts, probably 
by inhibition of a Cl
-
/HCO3 exchanger on the apical membrane of pancreatic duct 
cells (Hegyi et al., 2003). 
1.3.8 Therapeutic options targeting SP-NK1R pathway 
 
Although the pathological role of SP has been studied for over forty years, 
therapeutic options that target the SP-NK1R pathway are still very limited at this 
stage. Currently, the focus is on the development of clinically effective NK1R 
antagonist. Emend (also called Aprepitant or MK869), as a selective antagonist of 
NK1R, was the first drug of this class to be approved for clinical use in the United 
States (Patel and Lindley, 2003). Emend was described as an antiemetic, and being 
used as a prophylactic treatment for chemotherapy-induced emesis since its approval 
in 2003. Several NK1R antagonists underwent clinical trials for use in central nervous 
system disorders and irritable bowel syndrome, but further trials are needed to ensure 
their safety (Quartara and Altamura, 2006; Zakko et al., 2011). NK1R antagonists 
might also be a potential target for cancer therapy (Munoz et al., 2010).  
Clinical results derived from the use of NK1R antagonists were promising. 
However, other mechanisms that interfere with SP-NK1R interaction, such as 
inhibition of SP release from nerve endings, have not gained sufficient attention to 
date. Therefore, there is still a lot of potential to develop therapeutic options that 






 At present, the mechanisms that propagate inflammation in AP are still 
incompletely understood. Evidence derived from animal models of AP suggested that 
SP-NK1R interaction may play an important role in the pathogenesis of AP. Both SP 
and NK1R were found to be expressed in murine pancreatic acinar cells (Tamizhselvi 
et al., 2007). In addition, their expression was up-regulated in the local inflamed 
tissue. An elevated SP and NK1R expression could potentially increase SP-NK1R 
interaction and contribute to exaggerated inflammation.  
In light of this information, the focus of the present study is to investigate the 
expression of SP and NK1R in caerulein-induced AP models, and the underlying 
mechanisms involved. More specifically, by using a murine in vitro and in vivo AP 
model, this study sought to examine:  
 Expression levels of SP and NK1R in caerulein-stimulated pancreatic acinar 
cells. 
 The signaling mechanisms that mediate the expression of SP and NK1R in 
caerulein-stimulated pancreatic acinar cells. 
 The expression and activity of NEP using both cellular and animal models of 
caerulein-induced AP. 
 To determine how NEP activity affects SP expression and the outcome of AP 
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It is getting clear that SP binding to NK1R is involved in pro-inflammatory 
effects of experimental pancreatitis. Despite the clear pathogenic role of SP in AP, 
mechanisms that regulate their expression levels were not clear during the course of 
AP. In a previous study, gene expression of PPTA and NK1R was detected in isolated 
pancreatic acinar cells (Tamizhselvi et al., 2007). Protein levels of SP were also 
detected in acinar cell lysates, using an ELISA based method. However, the effects of 
caerulein on pancreatic acinar cells were not thoroughly investigated. As pancreatic 
acinar cells represent the bulk of pancreatic mass, SP produced by these cells might 
contribute significantly to local availability of SP. Moreover, activation of NK1R was 
found to up-regulate chemokines, which include MIP-1, MIP-2 and MCP-1, in 
pancreatic acinar cells(Ramnath and Bhatia, 2006). Therefore, we aim to investigate 
the effects of caerulein on mouse pancreatic acinar cells, to see its effect of the 
expression of SP and its receptor, NK1R.  
2.2 MATERIALS AND METHODS 
2.2.1 Animals and chemicals.  
All experimental procedures were approved by the Animal Ethics Committee 
of the National University of Singapore and carried out in accordance with 
established International Guiding Principles for Animal Research. Swiss mice (Male, 
25-30 grams) were acclimatized in a controlled environment with an ambient 
temperature of 23
o
C and a 12:12-hour light-dark cycle. Caerulein, a CCK analogue, 
was purchased from Bachem California (Torrance, CA) and dissolved in normal 
saline. The CCKA receptor antagonist, devazepide, was purchased from Tocris 
Bioscience (Ellisville, MO) and dissolved in dimethyl sulfoxide (DMSO). Glucose, 
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N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), and soybean trypsin 
inhibitor were obtained from Sigma-Aldrich (St.Louis, MO). Type IV collagenase 
was purchased from Worthington (Freehold, NJ). All chemicals were purchased with 
the highest purity available. 
2.2.2 Preparation of Pancreatic Acini.  
 Primary pancreatic acini were obtained from mouse pancreas by a collagenase 
dispersion method. Swiss mice were first euthanized by a lethal dose of sodium 
pentobarbitone (150mg/kg, i.p.). Fresh pancreas were infused with buffer A (mM: 
140 NaCl, 4.7 KCl, 1.13MgCl2, 1CaCl2, 10 glucose, and 10 HEPES, and 0.5mg/ml 
soybean trypsin inhibitor, pH 7.3) containing 200IU/ml Type IV collagenase. The 
pancreas was then minced and placed in 12mL of buffer A containing 200IU/ml Type 
IV collagenase, and incubated in a shaking water bath for 10 minutes at 37ºC. To 
obtain dispersed acini, the digested tissue was passed through small pipette tips. The 
cells were then passed through a solution of 50mg/ml bovine serum albumin 
(Dissolved in buffer A) and then washed twice with buffer A before further 
experiments. The viability of pancreatic acinar cells was determined by trypan blue 
exclusion assay. Cell preparations with at least 95% viability were used for further 
experiments.  
2.2.3 Treatment of Pancreatic Acinar Cells.   
Isolated pancreatic acinar cells were treated with caerulein. In concentration-





M for 60 minutes in a 37ºC water bath. To study the time-dependent 
effect of caerulein, pancreatic acinar cells were incubated with caerulein (10
-7
M) for 
0-120 minutes. For other experiments, cells were pre-treated with a selective CCKA 





2.2.4 Substance P extraction and detection.  
 SP was concentrated and detected according to manufacturer’s instructions 
(Bachem, CA). Briefly, treated pancreatic acinar cells were homogenized in ice-cold 
SP assay buffer (Bachem). A small amount of supernatant was kept for subsequent 
DNA assay, and the remaining supernatant was adsorbed on C18 cartridge columns 
(Bachem). The adsorbed peptides were eluted with 1.5ml of 75% acetonitrile (Bhatia 
et al., 1998). They were freeze-dried overnight and reconstituted with 55l of SP 
assay buffer. SP content was then determined with an ELISA kit (Bachem) according 
to manufacturer’s instructions. The results were quantified by spectophotometry at 
450nm. The results were then normalized with DNA content of the acinar cell 
samples. SP expression was corrected and presented as nanograms per microgram of 
DNA. 
2.2.5 DNA assay 
Determination of DNA concentration in the samples was performed 
fluorometrically as described by Labarca and Paigen (Labarca and Paigen, 1980). 
Briefly, cellular or tissue homogenates were incubated with Hoechst dye 33258 
(Sigma-Aldrich, Singapore). Calf thymus DNA of known concentration was used as a 
standard. The fluorescence intensity was determined under a wavelength of 340nm. 
The DNA concentration of the sample was then determined with reference to a linear 
standard curve.   
2.2.6 RNA isolation and reverse transcription 
 Total RNA from the pancreatic acinar cells was extracted with TRIzol reagent 
(Invitrogen, Singapore) according to the manufacturer’s instructions. All the steps 
were done on ice-cold conditions. Briefly, cells were homogenized in 1ml of TRIzol 
reagent and mixed with chloroform. After centrifugation, the transparent aqueous 
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layer was collected and mixed with isopropanol in a 1:1 ratio in order to precipitate 
RNA. After centrifugation, the resulting pellet was washed twice with 70% ethanol 
and dried. The dried pellet was then dissolved in RNase-free water for determination 
of RNA concentration and subsequent PCR analysis. The integrity of RNA was 
verified by ethidium bromide staining for the presence of distinct 28S and 18S bands 
on a 1.2% agarose gel (Figure 2.1). One microgram (1g) of total RNA was reverse 
transcribed using iScript cDNA synthesis kit (Bio-Rad, USA) into a total volume of 
20l, according to manufacturer’s instructions.   
 
Figure 2.1 RNA integrity was determined by the presence of distinct 28S and 18S 
rRNA bands.  
2.2.7 Semi-quantitative RT-PCR analysis.  
 2µl of cDNA was used as a template for PCR amplification by using PCR 
master mix from iDNA (Singapore). No reverse-transcriptase controls and no 
template control were performed to ensure that no genomic DNA and PCR reagent 
contamination is present. 3mM Mg
2+
 was added to the PCR reactions. PCR reaction 
mix was first denatured at 95°C for 3 minutes, followed by a optimal cycle number 
which is in the linear range of amplification. Each cycle consisted of of 95°C for 30 
seconds, annealing step (Table 2.1) for 30 seconds, and a 72°C elongation step for 45 
seconds. The final extension was at 72°C for 10 minutes. PCR products were 
analyzed on 1.2% w/v agarose gels containing 0.5g/ml ethidium bromide. The 
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ribosomal RNA, r18S, was used as a housekeeping gene to normalize the mRNA 
expression of PPTA and NK1R.  
The primer sequences are as follows:  
Table 2.1 PCR primer sequences, amplification cycles, annealing temperatures, and 


















Sense:        5’- CTTGCCTTTTGGAACCGTGTG-3’ 






Sense:        5’- CGCGATGCAGAACTACGAAA-3’ 





2.2.8 Quantitative real-time PCR analysis.  
2l of cDNA was used as a template for PCR amplification by using SYBR-green 
PCR master mix from Roche Diagnostics (Singapore). No template controls and 
intron spanning primers were used. All reactions were done in duplicates. PCR 
reaction mix was first subjected to 95°C for 5 minutes, followed by a 45 cycles of 
amplification. Each cycle consisted of 95°C for 30 seconds, annealing temperature of 
55
o
C for 15 seconds, and elongation temperature of 72°C for 15 seconds. -actin was 
used as a housekeeping gene to normalize the mRNA expression for real-time PCR 
experiments. The primer sequence of NK1R was re-designed to shorten its product 
size and better suit real-time PCR conditions. Expression of PPTA, NK1R, NEP and 
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-actin was determined using the “crossing point (Cp)” of the sample, where Cp is 
the point (cycle number) at which the fluorescence of a sample rises above the 
background fluorescence. 
The primer sequences are as follows:  
Table 2.2 PCR primer sequences, amplification cycles, annealing temperatures, and 
product sizes for quantitative real-time PCR 
Gene  
 (GenBank Accession No.) 
Primer sequence Size (bp) 
β-actin  
(NM_007393) 
Sense:       5’- TGTTACCAACTGGGACGACA-3’ 




Sense:        5’- GCTGCCCTTCCACATCTTCT-3’ 




Sense:        5’- CGCGATGCAGAACTACGAAA-3’ 




Sense:        5’- CAGCCTCAGCCGAAACTACA-3’ 
Antisense:  5’- GCAAAAGCCGCTTCCACATA-3’ 
156 
 
2.2.9 Whole cell lysate preparation and Western blot analysis.   
After treatment of pancreatic acinar cells, they were homogenized on ice in 
radioimmunoprecipitation assay (RIPA) lysis buffer supplemented with protease 
inhibitor cocktail (Roche, Switzerland) and phosphatase inhibitor cocktail (Sigma-
Aldrich). Protein concentrations
 
were determined by the Bradford protein assay (Bio-
rad, CA). Protein samples (80 µg) were separated by 10% SDS-polyacrylamide gels 
and electrophoretically transferred to polyvinylidene difluoride (PVDF) membranes. 
Non-specific binding was blocked by 1-hour incubation of the membranes in 5% 
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nonfat dry milk in PBST (0.05% Tween 20 in PBS). The blots were then incubated 
overnight with primary antibody NK1R (Abcam, UK) at 1:1000 dilutions in the 
buffer containing 2.5 % nonfat dry milk in PBST. After which they were washed four 
times with PBST, and finally incubated for 2 h with goat anti-rabbit HRP-conjugated 
secondary antibody (Santa Cruz Biotechnology, CA) at 1:2000 dilutions in the buffer 
containing 2.5 % nonfat dry milk in PBST. Membranes were washed and then 
incubated in SuperSignal™ West Pico chemiluminescent substrate (Pierce, IL) before 
exposure to X-ray films (CL-Xposure™, Pierce). Hypoxanthine-guanine 
phosphoribosyltransferase (HPRT) (Santa Cruz Biotechnology) was applied as an 
internal control to normalize protein loading. The intensity of bands was quantified 
using LabWorks™ Image Analysis software (UVP, CA).  
2.2.10 Statistical analysis.   
The data were expressed as the mean ± standard error of mean (SEM). The 
significance of changes among groups was evaluated by using ANOVA with a 





2.3.1 Caerulein induces PPTA mRNA expression and SP protein expression  
 
Freshly isolated pancreatic acinar cells were assessed for PPTA and SP expression 













M; 60 minutes) and 
time (0, 30, 60, 120 minutes; 10
-7
M caerulein) to determine the time- and 
concentration- dependant response. After treatment, RNA was extracted for detection 
of PPTA mRNA expression by semi-quantitative RT-PCR (Figure 2.2A) or 
quantitative real time-PCR (Figure 2.2B). SP was detected using a commercially 
available ELISA kit. Our results showed that caerulein increased expression of both 
gene and protein expression of SP. Caerulein-induced SP up-regulation was evident at 
a dose from 10
-8
M and there was a 3 fold increase at a concentration of 10
-7
M (Figure 
2.2C).  Densitometric analysis of PCR products on agarose gel showed that PPTA 
mRNA expression showed an increasing trend at a dose of 10
-8
M, and was 
significantly different to the expression of the control when caerulein concentration 
was 10
-7
M (Figure 2.2A).  Although statistically significant, the increase in PPTA 
mRNA (1.5 fold) transcription appeared small relative to SP.  After determining the 
effective concentration for PPTA stimulation, we performed a time-dependant study 
to investigate how rapidly PPTA responded to caerulein. Cells were treated with 
caerulein (10
-7
M) for 0, 30, 60, and 120 minutes, and our results showed that mRNA 
expression of PPTA was up-regulated between 30-60 minutes and is significantly 
different from the control at the 60 minute time point. The up-regulated response was 





Figure 2.2 Caerulein induces PPTA mRNA expression, and also SP peptide 





M; A) for 60 minutes. PPTA expression was determined with 
RT-PCR (Fig 2.2A) or real-time PCR (Fig 2.2B). SP expression was determined by a 
commercially available ELISA kit. PPTA expression was normalized with r18S/-
actin expression and SP levels were normalized with DNA content in the samples. A) 
Concentration response study on PPTA mRNA expression. B) Time response study 
on PPTA mRNA expression. C) Concentration response study on SP expression. 
Results are expressed as the means ± SEM from 4-6 independent experiments. 




2.3.2 Caerulein induces NK1R mRNA and protein expression 
 
The effect of caerulein on expression of NK1R, a high affinity receptor of SP, 
was also assessed using our pancreatic acinar cell model. Freshly isolated pancreatic 













M) for 60 minutes. After treatment, RNA was extracted for detection of 
NK1R mRNA expression by RT-PCR. NK1R protein expression was detected using 
Western blot. Our results showed that caerulein increased both the expression of 
mRNA and protein of NK1R. Caerulein-induced NK1R up-regulation was evident 
only at a high concentration of 10
-7
M, while lower concentrations showed minimal 
effects (Figure 2.3A).  The time-dependent response of NK1R mRNA expression was 
similar to time-dependent response of PPTA mRNA expression, which showed 
significant increases in 1 hour (Figure 2.3B). In contrast, protein expression of NK1R 
required a longer stimulation time of 2 hours to show significant increases (Figure 
2.3C).  Overall, our preliminary results showed that caerulein concentrations below 
10
-8
M did not induce up-regulation of SP and NK1R. Therefore, a concentration of 
10
-7




Figure 2.3 Caerulein induces NK1R gene and protein expression in the pancreatic 
acinar cells. Freshly prepared cells were treated with caerulein (10-12M to 10-7 M; A) 
for 60 minutes or caerulein (10
-7
M; B) for 0-120 minutes. NK1R gene expression was 
determined with RT-PCR (Figure 2.3A) or real-time PCR (Fig 2.3B). NK1R protein 
expression was determined by Western blot. NK1R mRNA expression was 
normalized with r18S/β-actin expression and NK1R protein levels was normalized 
with HPRT expression in the samples. A) Concentration response study on NK1R 
mRNA expression. B) Time response study on NK1R mRNA expression. C) Time 
response study on NK1R protein expression. Results are expressed as the means ± 
SEM from 4-6 independent experiments. *P<0.05 vs. control.  
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2.3.3 SP expression is mediated via CCKA receptors 
 
Previous studies have mostly attributed the effect of caerulein to the 
stimulation of CCKA receptors in pancreatic acinar cells. In this study, we tested 
whether caerulein binding on CCKA receptors mediates SP up-regulation in pancreatic 
acinar cells. Pancreatic acinar cells were pre-treated with different concentrations of 
devazepide, a specific CCKA antagonist, for 30 minutes before stimulated with 
caerulein (10
-7
M) to induce maximum response. Devazepide treatment is able to 
abolish the up-regulation of SP. Devazepide concentrations less than 10 nM showed a 
trend to decrease SP levels in the pancreatic acinar cells, but they were not 
statistically significant. However, pretreatment of cells with more than 10 nM 
devazepide showed significant reversal of SP up-regulation, whereas a concentration 
of 1 µM completely abolished the increase in SP production caused by caerulein 






Figure 2.4 Caerulein induced SP up-regulation is mediated by CCKA signaling. 
Pancreatic acinar cells were pre-treated with different concentrations of devazepide 
for 30 minutes before caerulein (10
-7
M) stimulation for 60 minutes. SP expression 
was determined by a commercially available ELISA kit. Results are expressed as the 






In experimental AP models, SP has been shown to be up-regulated and 
plays a proinflammatory role (Lau and Bhatia, 2006). SP and NK1R are expressed 
in the pancreatic acinar cells, and this expression could contribute to the overall 
outcome of caerulein-induced AP.  
Our results showed that treatment of pancreatic acinar cells with caerulein 
up-regulated the gene expression of PPTA and NK1R, and also the protein levels of 
SP. The changes were found to be concentration-dependent. At a physiological 
concentration of caerulein (10
-10
M), the expression of PPTA, NK1R, and SP 
remained at the basal level. However, at a supramaximal concentration of caerulein 
(10
-7
M), mRNA expression of PPTA and NK1R was significantly up-regulated. On 
the other hand, SP expression was significantly increased at a lower concentration 
of 10
-8
M.  The up-regulation of SP was also substantially stronger than the up-
regulation of its gene, PPTA (3- to 1.5-fold compared with control). It is possible 
that RNA stabilization, increased translational activity or reduced degradation of 
the SP product by neutral endopeptidases might contribute to the results observed, 
although these hypotheses remain to be elucidated (Estival et al., 1991; O'Connor 
et al., 2004). The 3-fold increase in SP levels is in line with previous experiments 
done in vivo, in which SP is increased with a similar magnitude in the pancreas 
after induction of AP (Lau and Bhatia, 2006). A time dependent study using 
supramaximal concentrations of caerulein also clearly showed a slow but steady 
increase of NK1R protein expression in mouse pancreatic acinar cells, and is 
statistically significant after two hours of caerulein exposure. These findings 
showed that the up-regulation of SP/NK1R was rapid upon induction of AP, 
further showing its importance in mediating the early phase of the disease.  
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Administration of a selective CCKA antagonist, devazepide, inhibited the 
expression of SP. A concentration of 10 nM is able to cause a significant down-
regulation of SP, whereas a concentration of 1µM completely reversed SP 
expression to basal levels. Because the effective inhibitory concentration of 
devazepide is well below the IC50 for CCKB, along with the very low expression of 
CCKB receptors in mouse pancreas, we suggest that caerulein acts through CCKA 
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 Caerulein-induced activation of downstream secondary messengers was 
extensively studied in both cellular and animal models of AP. Caerulein was found to 
be able to activate three main members of the mitogen activated protein kinases 
(MAPK), which include extracellular signal-regulated kinase (ERK), c-Jun NH2-
terminal kinase (JNK) and p38. The activation of ERK and JNK is rapid. Both 
molecules were found to be induced by caerulein within 15 minutes and maintained 
their activated state for 2 hours in the rat pancreas (Namkung et al., 2008). When the 
animals received pre-treatment with an ERK or JNK inhibitor, they exhibit reduced 
pancreatic damage (Namkung et al., 2008). In another study, treatment of rats with 
CEP-1347, a JNK inhibitor, protected mice against caerulein-induced pancreatitis 
(Wagner et al., 2000).  
Protein kinase C (PKC) was also activated in caerulein-induced pancreatic 
acinar cells. Treatment of cells with caerulein causes translocation of PKC to the cell 
membrane (Bruzzone et al., 1988). However, the exact role of PKC in caerulein-
induced pancreatic acinar cells was not clear. Two members of the PKC family, 
PKC and PKC, were found to be activated and involved in the modulation of 
zymogen activation in pancreatic acinar cells (Thrower et al., 2008). On the other 
hand, caerulein was also able to cause activation of eIF4E-binding protein and S6 
ribosomal protein by a protein kinase B dependent pathway (Sans et al., 2003). 
In this study, we have focused on the role of PKC, MAPK and transcription 
factors NF-B and AP-1 in the regulation of SP/NK1R expression in pancreatic 
acinar cells.  




The MAPKs are a family of serine/threonine kinases that are widely 
implicated in physiological and pathological responses. MAPKs can be divided into 
six distinct groups, in which the ERK, JNK, and p38-MAPK are best characterized 
(Krishna and Narang, 2008). MAPK activation cascades are organized in which 
phosphorylation of an upstream kinase leads to sequential activation of the MAPK 
downstream molecules (MAPKKK  MAPKK  MAPK) (Chang and Karin, 2001). 
In other words, phosphorylation and dephosphorylation of MAPKs at activation sites 
enable it to regulate cellular functions. The MAPKs respond to growth and stress 
signals, and is implicated in the control of cell division, cell death, and pathological 
responses. In experimental pancreatitis models, three members of the MAPK, which 
include ERK, JNK and p38, were found to be activated. Treatment with MAPK 
inhibitors down-regulates MAPK signaling and showed protective effects, suggesting 
the important role of MAPKs in the pathogenesis of AP (Samuel et al., 2006; 
Namkung et al., 2008).  
Activated MAPKs will then phosphorylate an array of downstream kinases, 
and eventually lead to the activation of gene regulating transcription factors. In this 
present study, we have focused on the role of ERK and JNK pathways, and also the 
transcription factors NF-B and AP-1, in caerulein induced SP/NK1R expression in 
pancreatic acinar cells.  
3.1.2 Transcription factors NF-B and AP-1 
Nuclear factor-kappa B (NF-B) and activator protein-1 (AP-1) are 
transcription factors frequently associated with inflammatory response in AP 
(Gukovsky et al., 2003; Ramnath and Bhatia, 2006; Rakonczay et al., 2008b). In the 
cytoplasm, NF-B is inhibited by IB. During a stimulus, phosphorylation of IB by 
IB kinase (IKK) leads to IB degradation through the 26S proteosome. The nuclear 
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translocation signal of NF-B was then exposed and translocated into the nucleus. 
NF-B is composed of homodimers or heterodimers of two subunits from a family of 
Rel proteins, which include p50, p52, p65, RelB, and c-Rel. In particular, the p65 
subunit was suggested to be responsible for a strong transcription activity of NF-B 
(Schmitz and Baeuerle, 1991).  
AP-1 is a heterodimer which consisted of c-Jun, c-Fos, or ATF. The subunits 
of AP-1 share a leucine zipper motif that facilitates dimerizaton, and also a DNA 
binding domain is responsible for transcriptional activity. AP-1 was well known to be 
activated by JNK, but other members of the MAPKs, such as ERK, were also found 
to be able to activate AP-1 (Xu et al., 2006; Guedea et al., 2011). The activation of 
these transcription factors is rapid, allowing a fast response of transcriptional activity 
when a stress signal is available. Both NF-B and AP-1 are widely implicated in the 
regulation of genes that code for inflammatory mediators. In neuronal models, NF-B 
regulates the expression of PPTA and it is known that there are multiple AP-1 
response elements in the proximal region of its promoter (Paterson et al., 1995; 
Fiskerstrand et al., 1997). The flanking region of the NK1R gene also has a NF-B 
transcriptional regulation site (O'Connor et al., 2004). 
3.1.3 Protein kinase C 
In recent years, the role of protein kinase C (PKC) has been extensively 
studied in the pathogenesis of AP. There are more than 10 isoforms of PKC divided 
into three different classes, namely, conventional, novel and atypical PKC. The 
conventional PKC isoforms ,, and  are regulated by Ca2+ and diacylglycerol 
(DAG). On the other hand, novel PKC isoforms ,,, and respond to DAG, but do 
not involve Ca
2+
. The atypical PKC isoforms ,  and  are different as their 
 46 
  
activation does not need the presence of Ca
2+
 and DAG (Mellor and Parker, 1998). In 
the pancreatic acinar cells, the conventional PKC and novel PKC,  and atypical  
isoforms had been identified (Bastani et al., 1995). In general, the activation of PKC 
is characterized by the phosphorylation of the molecule, followed by translocation of 
distinct intracellular compartments in which it performs its specific function (Shirai 
and Saito, 2002). The individual roles of PKCs in the regulation of pancreatic acinar 
function have been reported in various studies, where PKC is the most studied. 
PKC is activated and translocated to the plasma membrane and participates in 
CCK/caerulein-stimulated secretion (Li et al., 2004) and protease activation (Thrower 
et al., 2009) in pancreatic acinar cells. PKC was also found to modulate 
inflammatory molecule expression in the SP-induced pancreatic acinar cells 
(Ramnath et al., 2008). The role of conventional PKC is less understood, but with 
CCK treatment stimulates increases in Ca
2+
 and DAG in the pancreatic acinar cells, a 
potential role of PKC cannot be ruled out (Williams, 2001).  
3.1.4 Concluding remarks 
 
In chapter 2, we have elaborated the concentration and time dependent effect 
of caerulein on SP/NK1R expression in isolated murine pancreatic acinar cells. In this 
chapter, we investigated intracellular mechanisms that might lead to SP/NK1R up-
regulation, using specific pharmacological inhibitors. To our knowledge, this is the 
first report of the detailed mechanisms that regulate the expression of SP and NK1R 
in pancreatic acinar cells. Elucidation of key signaling molecules involved in the 
regulation of SP/NK1R pathway contribute to understanding how inflammatory 




3.2 MATERIALS AND METHODS 
3.2.1 Animals and chemicals.  
Refer to section 2.2.1. Swiss mice (Male, 25-30 grams) were used for isolation 
of pancreatic acinar cells. PD98059 (Mitogen-activated protein kinase kinase (MEK) 
inhibitor), SP600125 (JNK inhibitor), Bay11-7082 (NF-B inhibitor), Gö6976 
(PKC/ inhibitor) and rottlerin (PKC inhibitor), were purchased from Calbiochem 
(Darmstadt, Germany). They were dissolved in DMSO. All chemicals were purchased 
with the highest purity available. 
3.2.2 Preparation and treatment of pancreatic acinar cells.   
Refer to section 2.2.2 and 2.2.3. For concentration dependent studies, 
pancreatic acinar cells were treated with different concentrations of caerulein for 60 
minutes; for time dependent studies, cells were incubated with caerulein (10
-7
M) for 
0-120 minutes. In order to study the signaling mechanisms involved, isolated 
pancreatic acinar cells were pre-treated with PD98059, SP600125 or Bay11-7082 for 
30 minutes before treatment with caerulein (10
-7
M, 60 minutes). Similarly, cells were 
pre-treated with rottlerin or Gö6976 for 45 minutes before stimulation with caerulein.  
3.2.3 Substance P extraction and detection.  
Refer to section 2.2.4. 
3.2.4 Whole cell lysate preparation and Western blot analysis. 
Refer to section 2.2.9. Cells were lysed with RIPA lysis buffer and protein 
concentrations were determined by Bradford protein assay. 50-80 µg of total cell 
lysate from each sample were subjected to Western blot analysis. The blots were 









), total JNK, phospho-PKC (Thr638), phospho-
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PKC Thr505), phospho-IB (Ser32), total IB, or HPRT at 1:1000 dilutions. After 
washing away the primary antibodies, the membranes were incubated for 2 hours with 
goat anti-rabbit HRP-conjugated secondary antibody at 1:2000 dilutions. Protein 
expression was then detected by adding SuperSignal™ West Pico chemiluminescent 
substrate before exposure to X-ray films. 
3.2.5 Nuclear cell extract preparation and NF-B/AP-1 DNA-binding activity.  
Nuclear cell extracts were prepared by using Nuclear Extract Kit (Active 
Motif, CA). In brief, cells were washed in ice-cold PBS in the presence of 
phosphatase inhibitors. After centrifugation, the cell pellets were re-suspended in a 
hypotonic buffer, treated with detergent and centrifuged at 14,000 g for 30 sec. After 
removing of the cytoplasmic fraction, the pellet (nuclei) was lysed with lysis buffer 
containing protease inhibitors and nuclear proteins solubilise in the lysis buffer. 
Nuclear protein concentrations were determined by Bradford protein assay (Bio-Rad). 
The binding of nuclear NF-B and AP-1 to DNA was measured with ELISA based 
NF-B p65 assay kit and AP-1 c-Jun assay kit respectively (Active Motif). The plates 
were pre-coated with an unlabeled oligonucleotide containing the consensus-binding 
site (NF-B p65: 5’-GGGACTTTCC-3’; AP-1 c-Jun: 5’ –TGAGTCA-3’). Nuclear 
proteins (20 μg) were used for the assay and the results were quantified by 
spectophotometry at 450nm. 
3.2.6 Semi-quantitive RT-PCR analysis and Quantitative real time PCR analysis.  
Refer to section 2.2.6, 2.2.7 and 2.2.8.  
3.2.7 Statistical analysis.   





3.3.1 Caerulein stimulates ERK and JNK phosphorylation in a concentration 
dependent manner 
To investigate the possible involvement of MAPKs, a concentration-response 













M) for 60 minutes and 
whole cell lysates were subjected to Western blot analysis. Both ERK1/2 and JNK 
were significantly activated only at a concentration of 10
-7
M, as shown by the 
increased phosphorylation. Lower concentrations of caerulein do not appear to affect 
the phosphorylation of ERK and JNK (Figure 3.1A, 3.1B). The concentration of 
caerulein to stimulate phosphorylation of ERK and JNK was in line with the 






Figure 3.1 Caerulein treatment activates ERK and JNK in pancreatic acinar cells. 




M) for 60 minutes. ERK and JNK 
activation was determined by Western blotting. Whole cell lysates were prepared for 









), and ERK. A) Concentration response study of ERK activation. B) 
Concentration response study of JNK activation. Results are expressed as the means± 
SEM from four to six independent experiments.*P<0.05vs. control   
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3.3.2 PD98059 and SP600125 inhibits ERK and JNK respectively in the 
pancreatic acinar cells 
PD98059 and SP600125 are known inhibitors of ERK and JNK respectively. 
The effective concentrations for ERK and JNK inhibition in caerulein-stimulated cells 
were investigated. Cells were pre-treated with PD98059 or SP600125 for 30 minutes 
to allow permeation into the cells. PD98059 and SP600125 attenuated caerulein-
induced phosphorylation of ERK and JNK, respectively, in a concentration dependent 
manner (Figure 3.2A, 3.2B). The inhibition of ERK phosphorylation was significant 
when cells were pre-treated with 30M and 50M of PD98059 (Figure 3.2A). On the 
other hand, concentrations of 30M and 50M were found to inhibit JNK 





Figure 3.2 PD98059 and SP600125 inhibited ERK and JNK activation respectively 
in pancreatic acinar cells. Cells were pre-treated with PD98059 or SP600125 for 30 
minutes before treatment with caerulein (10
-7
M) for 60 minutes.  ERK and JNK 
phosphorylation was determined by Western blotting. Whole cell lysates were 









) and JNK.  A) ERK phosphorylation after treated with PD98059. 
B) JNK phosphorylation after treated with SP600125. Results are expressed as means 




3.3.3 Caerulein-induced PPTA/SP up-regulation is dependent on JNK activation, 
but not ERK activation 
We have previously shown that a caerulein concentration of 10
-7
M 
significantly up-regulated PPTA mRNA transcription and SP expression in pancreatic 
acinar cells. We tested whether inhibition of ERK or JNK could attenuate PPTA/SP 
up-regulation. It was found that treatment of cells with 30M SP600125 significantly 
attenuated the up-regulation of PPTA/SP (Figure 3.3A, 3.3B). This concentration is 
similar to the concentration required to inhibit JNK (Figure 3.2B). However, 
treatment with PD98059 does not appear to cause any significant reduction of 





Figure 3.3 The role of ERK and JNK pathways in mediating the increased expression 
of PPTA and SP. Cells were pre-treated with PD98059 or SP600125 for 30 minutes 
before treatment with caerulein (10
-7
M) for 60 minutes. PPTA mRNA expression was 
determined with RT-PCR and normalized with r18S expression. SP levels were 
determined by a commercially available ELISA kit and normalized with DNA content 
in the samples. A) SP expression. B) PPTA mRNA expression. Results are expressed 
as the means ± SEM from 4-6 independent experiments. *P<0.05 vs. control, #P<0.05 
vs. caerulein.   
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3.3.4 Caerulein treatment induces NK1R gene expression via ERK and JNK 
dependent pathways 
We also tested the possible role of ERK and JNK in NK1R mRNA expression. 
As opposed to the expression of PPTA/SP, pre-treatment of pancreatic acinar cells 
with both 50µl of PD98059 or SP600125 significantly inhibited NK1R expression 
(Figure 3.4).  
 
Figure 3.4 The role of ERK and JNK pathways in mediating the increased expression 
of NK1R. Cells were pre-treated with PD98059 or SP600125 for 30 minutes before 
treatment with caerulein (10
-7
M) for 60 minutes. NK1R mRNA expression was 
determined with RT-PCR and was normalized with r18S expression. Results are 
expressed as the means ± SEM from 4-6 independent experiments. *P<0.05 vs. 
control, #P<0.05 vs. caerulein.  
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3.3.5 Caerulein stimulates NF-B and AP-1 
Given the importance of NF-B and AP-1 transcription factors in 
inflammatory molecule expression, we examined the activation profile of NF-B and 
AP-1 in caerulein-treated pancreatic acinar cells. Phosphorylation and subsequent 
degradation of IB is required for NF-B activation. Therefore, IB degradation was 
also examined. Caerulein treatment induced substantial activation of NF-B and AP-1, 
as reflected by the increased DNA binding activity (Figure 3.5A, 3.5B). IB 
degradation was also significant in pancreatic acinar cells treated with 
supraphysiological concentrations of caerulein (Figure 3.5C). Caerulein 
concentrations below 10
-7






Figure 3.5 Caerulein induces AP-1 and NF-B activity in the pancreatic acinar cells. 





for 60 minutes. Whole-cell lysates were prepared for Western blot analysis of IB and 
HPRT. Nuclear NF-B and AP-1 DNA binding activity was determined by using a 
commercially available ELISA kit. A) Concentration response study of AP-1 DNA 
binding activity. B) Concentration response study of NF-B DNA binding activity. C) 
Concentration response study of IB degradation. Results are expressed as the means 
± SEM from 4-6 independent experiments. *P<0.05 vs. control.  
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3.3.6 Effect of PD98059 and SP600125 on DNA binding activity of NF-B and 
AP-1 
The ERK and JNK pathways were found to be upstream activators of NF-B 
and AP-1 in SP-induced chemokine production in the pancreatic acinar cells. To 
investigate the possibility that the ERK/JNK pathway contributes to NF-B/AP-1 
activation in caerulein-treated pancreatic acinar cells, we investigated the effects of 
PD98059 and SP600125 on NF-B/AP-1. The DNA binding activity of NF-B/AP-1 
was significantly suppressed after treatment with PD98059 and SP600125 (Figure 
3.6A, 3.6B). PD98059 and SP600125 also reduced the amount of phosphorylated IB 






Figure 3.6 ERK and JNK activation is involved in the DNA binding activity of NF-B 
and AP-1. Pancreatic acinar cells were pre-treated with PD98059 or SP600125 for 30 
minutes before stimulation with caerulein (10
-7
M, 60 minutes). Subsequently, nuclear 
extracts was obtained and AP-1 and NF-B DNA binding ability was determined by 
using a commercially available ELISA kit. Whole cell lysates were prepared for 
Western blot analysis for phospho-IB and HPRT. A) AP-1 DNA binding activity. B) 
NF-B DNA binding activity and representative blot for phospho-IB levels in whole 
cell lysates. Results are expressed as the means ± SEM from 4-6 independent 
experiments. *P<0.05 vs. control, #P<0.05 vs. caerulein.   
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3.3.7 Effect of Bay 11-7082 on the expression of SP, PPTA and NK1R.  
We investigated the effect of the NF-B inhibitor Bay 11-7082 on the 
expression of SP, PPTA and NK1R. It was found that treatment with Bay 11-7082 
significantly attenuated the up-regulation of SP, PPTA and NK1R, although the 
effective concentrations are different (Figure 3.7 A-C). Bay 11-7082 at a 10µM 
concentration significantly reduced the expression of NK1R, whereas a concentration 





Figure 3.7 Bay 11-7082, a NF-B inhibitor, inhibited the expression of SP, PPTA and 
NK1R. Freshly prepared pancreatic acinar cells were pre-treated with Bay 11-7082 for 
30 minutes before stimulation with caerulein (10
-7
M, 60 minutes). NK1R and PPTA 
mRNA expression was determined with RT-PCR and SP levels were determined by a 
commercially available ELISA kit. NK1R and PPTA expression was normalized with 
r18S expression and SP levels were normalized with DNA content in the samples. A) 
SP expression. B) PPTA mRNA expression C) NK1R mRNA expression. Results are 
expressed as the means ± SEM from 4-6 independent experiments. *P<0.05 vs. 
control, #P<0.05 vs. caerulein.  
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3.3.8 Caerulein induces phosphorylation of PKC and PKC in mouse 
pancreatic acinar cells 
Caerulein and its analogue CCK are known to activate PKC family in the 
pancreatic acinar cells. We examined the time-dependant phosphorylation of PKC 
and PKC in our model of caerulein-induced pancreatic acinar cells. To do this, 
freshly isolated pancreatic acinar cells were treated with caerulein (10
-7
M) for 2, 5, 15, 
30 and 60 minutesWestern blot analysis of the whole cell lysates showed a modest 
but significant increase in phosphorylation of both PKC and PKC. Both PKC and 
PKC are rapidly activated, with significant increases after 2 minutes of caerulein 
incubation. The activation of PKC was transient, as the phosphorylated molecules 
decreased after one hour of incubation (Figure 3.8B). On the other hand, PKC 
remained phosphorylated throughout the studied time course (Figure 3.8C). HPRT 





Figure 3.8 Caerulein induces phosphorylation of PKC and PKC in mouse 
pancreatic acinar cells.  Freshly prepared cells were treated with caerulein (10-7M) 
for 2, 5, 15, 30, and 60 minutes. Whole cell lysates were prepared and 50g of protein 
were fractionated on 10% SDS page gels for Western Blot analysis of phospho-
PKC (Thr638), phospho-PKC (Thr505) and HPRT. A) Representative blots of 
phospho-PKC and phospho-PKC from 6 independent experiments. B) Time 
response study on PKC phosphorylation. C) Time response study on PKC 
phosphorylation. Results are expressed as means ± SEM from 6 independent 
experiments. *P<0.05 vs. control.  
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3.3.9 Effect of Gö6976 and Rottlerin on PKC and PKCphosphorylation 
After determining the time course response of PKC and PKC, we proceed 
to investigate the effect of Gö6976 and rottlerin on PKC and PKCactivation. From 
the previous data, we chose a stimulation timing of 15 minutes, as the response at this 
time is greatest and more stable for both types of studied PKC. Pancreatic acinar cells 
were pre-treated with Gö6976 (1, 5 and 10nM) or rottlerin (1, 5 and 10) for 45 
minutes followed by caerulein (10
-7
M) stimulation. Western blot analysis indicate that 
Gö6976 (IC50=2.3nM) showed a concentration dependent inhibition of PKC and 
PKC phosphorylation is completely reversed at a concentration of 10nM (Figure 
3.9A). However, Gö6976 does not inhibit PKC at the concentrations used (Figure 
3.9B). On the other hand, rottlerin (IC50=3M) significantly inhibited PKC 
phosphorylation even at a low concentration of 1M (Figure 3.9C). Rottlerin pre-
treatment also showed a very small decrease of PKC activation when compared to 
the caerulein treated group but they are far from statistical significance (Figure 3.9D). 
Treatment of cells with the used inhibitors alone does not significantly affect the 








Figure 3.9 The effect of rottlerin and Gö6976 on PKC and PKC phosphorylation.  
Pancreatic acinar cells were pre-treated with Gö6976 (1-10nM) or rottlerin (1-10M) 
for 45 minutes before caerulein (10
-7
M) stimulation for 15 minutes. Whole cell 
lysates were prepared and 50g of protein were fractionated on 10% SDS page gels 
for Western blot analysis of phospho-PKCThr638), phospho-PKCThr505) and 
HPRT. A) Effect of Gö6976 on PKC phosphorylation. B) Effect of Gö6976 on 
PKC phosphorylation. C) Effect of rottlerin on PKC phosphorylation. D) Effect of 
rottlerin on PKC phosphorylation. Results are expressed as means ± SEM from 6 
independent experiments. *P<0.05, vs. control, #P<0.05 vs. caerulein.  
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3.3.10 PKC and PKCare involved in caerulein-induced SP up-regulation in 
mouse pancreatic acinar cells 
We have previously shown that caerulein hyperstimulation significantly up-
regulated SP peptide expression and its gene, PPTA, in mouse pancreatic acinar cells. 
To examine the involvement of PKC and PKC in this up-regulation, we pre-treated 
cells with Gö6976 and rottlerin. It was previously shown that Gö6976 and rottlerin 
are specific to PKC and PKC respectively (Figure 3.9A-D). By using quantitative 
real time PCR, caerulein (10
-7
M) significantly up-regulated PPTA mRNA expression 
when compared to the control. When the cells were pre-treated with Gö6976 or 
rottlerin, the gene expression of PPTA was significantly reduced (Figure 3.10A, 
3.10C).  In line with the observations for PPTA, the peptide expression of SP was 
significantly reversed with pre-treatment of Gö6976 or rottlerin, indicating that PPTA 
mRNA expression is one of the factors that mediate SP levels in pancreatic acinar 
cells (Figure 3.10B, 3.10D). Generally, there is a slight concentration dependant 
inhibitory effect observed for the experiments done, as there was a more complete 








Figure 3.10 Caerulein stimulates PKC and PKC mediated SP gene and protein 
expression. Freshly prepared pancreatic acinar cells were pre-treated with Gö6976 (1-
10nM) or rottlerin (1-10M) for 45 minutes before caerulein (10-7M) stimulation for 
60 minutes. PPTA mRNA expression was determined with real time PCR and SP 
levels were determined by a commercially available ELISA kit. PPTA mRNA 
expression was normalized with -actin expression and SP levels was normalized 
with DNA content in the samples. A) PPTA mRNA expression of cells treated with 
Gö6976. B) SP expression of cells treated with Gö6976. C) PPTA mRNA expression 
of cells treated with rottlerin. D) SP expression of cells treated with rottlerin. Results 
are expressed as means ± SEM from 4-6 independent experiments. *P<0.05 vs. 
control, #P<0.05 vs. caerulein.   
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3.3.11 PKC and PKCare involved in caerulein-induced NK1R up-regulation 
in mouse pancreatic acinar cells 
With also investigated the effect of PKC inhibition on the expression of 
NK1R. Using quantitative real time PCR, caerulein (10
-7
M) significantly up-regulated 
NK1R mRNA expression when compared to the control. When the cells were pre-
treated with Gö6976 or rottlerin, the gene expression of NK1R was significantly 
reduced (Figure 3.11A, 3.11C).  Pre-treatment with either Gö6976 or rottlerin also 









Figure 3.11 Caerulein stimulates PKC and PKC mediated NK1R gene and protein 
expression. NK1R mRNA expression was determined with real time PCR and protein 
expression was determined by Western blotting. NK1R mRNA expression was 
normalized with -actin expression and protein expression was normalized with 
HPRT expression in the samples. Freshly prepared pancreatic acinar cells were pre-
treated with Gö6976 (1-10nM) or rottlerin (1-10M) for 45 minutes before caerulein 
(10
-7
M) stimulation for 60 minutes (mRNA expression) or 120 minutes (protein 
expression). (A) NK1R mRNA expression of cells treated with Gö6976. (B) NK1R 
protein expression of cells treated with Gö6976. (C) NK1R mRNA expression of cells 
treated with rottlerin. (D) NK1R protein expression of cells treated with rottlerin. 
Results are expressed as means ± SEM from 4-6 independent experiments. *P<0.05 
vs. control, #P<0.05 vs. caerulein.   
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3.3.12 PKC and PKC are involved in caerulein induced ERK and JNK 
activation in mouse pancreatic acinar cells  
The role of PKCs in caerulein induced SP/NK1R activation was further 
studied by looking at possible downstream signalling molecules. Our previous results 
have shown that the up-regulation of SP and NK1R involves the activation of the 
MAP kinases ERK and JNK. To determine if PKC and PKC are involved in the 
activation of ERK and JNK, pancreatic acinar cells were treated with Gö6976 (1-
10nM) or rottlerin (1-10M) followed by caerulein stimulation. Western blot analysis 
of whole cell lysates revealed that ERK and JNK were significantly activated after 
stimulated with caerulein. Our results also showed that both Gö6976 and rottlerin 
inhibited the phosphorylation of ERK and JNK (Figure 3.12A-D). Furthermore, 
rottlerin treatment strongly inhibits JNK phosphorylation such that the rottlerin 
treated groups fell below control levels (Figure 3.12D). However, this decrease in 









Figure 3.12 The activation of ERK and JNK in mouse pancreatic acinar cells is 
dependent on both PKC and PKC. Freshly prepared pancreatic acinar cells were 
pre-treated with Gö6976 (1-10nM) or rottlerin (1-10M) for 45 minutes before 
caerulein (10
-7
M) stimulation for 60 minutes. Whole cell lysates were prepared and 









), and ERK. A) ERK 
activation of cells treated with Gö6976. B) JNK activation of cells treated with 
Gö6976. C) ERK activation of cells treated with rottlerin. D) JNK activation of cells 
treated with rottlerin. Results are expressed as means ± SEM from 4-6 independent 
experiments. *P<0.05vs. control, #P<0.05 vs. caerulein  
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3.3.13 Inhibition of PKC and PKC attenuates caerulein induced NF-B and 
AP-1 activation in mouse pancreatic acinar cells  
We examined the effect of Gö6976 and rottlerin on transcription factor NF-B 
and AP-1 in isolated pancreatic acinar cells. Nuclear fractions of treated cells were 
extracted. DNA binding activity was performed using an ELISA based method using 
nuclear fractions. Treatment of caerulein for 60 minutes significantly increased NF-
B and AP-1 DNA binding activity and this increase is attenuated by pre-treatment of 
cells with Gö6976 or rottlerin (Figure 3.13B, 3.13C). Due to a small difference 
observed in NF-B DNA binding activity, we used an indirect method, the 
phosphorylation of IB to further confirm NF-B activation. Whole cells lysates were 
used to perform Western blot, and the results shown a significant increase in IB 
phosphorylation, which was attenuated with Gö6976 or rottlerin pre-treatment (Figure 
3.13A). The trend of IB phosphorylation correlated with NF-B binding activity, 






Figure 3.13 PKC and PKC activation is involved in the DNA binding activity of 
NF-B and AP-1. Pancreatic acinar cells were pre-treated with Gö6976 (1-10nM) or 
rottlerin (1-10M) for 45 minutes before caerulein (10-7M) stimulation for 60 minutes. 
Subsequently, nuclear extracts was obtained and AP-1 and NF-B DNA binding 
ability was determined by using a commercially available ELISA kit. Whole cell 
lysates were prepared for Western blot analysis of phospho-IB (Ser32) and HPRT. A) 
Representative phospho-IB Western blot results and relative intensity are averages 
of 6 independent experiments. B) NF-B DNA binding activity. C) AP-1 DNA 
binding activity. Results are expressed as the means ± SEM from 6 independent 







Intracellular signaling molecules such as the MAPKs, cyclic AMP (cAMP), 
protein kinase C (PKC) and NF-B are known to be activated upon induction of AP 
(Tando et al., 1999; Lu et al., 2003; Bi and Williams, 2004; Thrower et al., 2008). 
Previous studies had showed that activation of ERK and JNK induced cytokine 
production and inhibition of ERK and JNK showed protective effects (Samuel et al., 
2006; Namkung et al., 2008; Samuel et al., 2008). In agreement with previous studies, 
we demonstrated that supraphysiological concentrations of caerulein treatment 
induced ERK and JNK phosphorylation. The observed results suggested that 
induction of ERK and JNK occurred when the cell was experiencing stress and injury; 
whereas at physiological stimulations the phosphorylation of ERK and JNK remained 
at basal levels.  
Studies utilizing small molecule MAPK inhibitors directly demonstrated the 
involvement of these molecules in SP/NK1R up-regulation. The MEK inhibitor 
PD98059 and JNK inhibitor SP600125 significantly inhibited the phosphorylation of 
ERK and JNK respectively in stimulated pancreatic acinar cells. We found that pre-
treatment of PD98059 on caerulein-stimulated pancreatic acinar cells attenuated the 
transcription of NK1R gene. On the other hand, SP600125 treatment attenuated the 
transcription of both PPTA and NK1R gene, as well as SP peptide. These results 
suggest that caerulein-induced up-regulation of SP and NK1R goes through different 
pathways. Activation of ERK is involved in NK1R expression and activation of JNK 
is involved in both NK1R and SP expression. This observation is not surprising as 
PPTA and NK1R are encoded by two entirely different genes, and thus their activation 
mechanism would be different. 
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The regulation of MAPKs depends on the phosphorylation and 
dephosphorylation at its activation site (Kondoh and Nishida, 2007; Boutros et al., 
2008).  We found that higher concentrations of PD98059 and SP600125 tended to 
downregulate ERK and JNK activation when compared to the control. However, 
these observations were not statistically significant. On the other hand, basal 
phosphatase activity continued to dephosphorylate ERK and JNK. Therefore, a shift 
in thebalance towards dephosphorylation caused a decrease of MAPK activity, and 
this might affect other cellular activities should the effect is significant. 
NF-B and AP-1 are transcription factors frequently linked to pathological 
inflammation and the up-regulation of inflammatory mediators (Ghosh and Hayden, 
2008; Zenz et al., 2008). Supraphysiological concentrations of caerulein treatment 
caused significant degradation of IB in the pancreatic acinar cells, but did not occur 
at lower concentrations of caerulein. We also observed that DNA binding activity of 
NF-B p65 subunit complies with caerulein-induced IB degradation in the 
pancreatic acinar cells. Our observations suggest that the conventional pathway of 
NF-B activation, which involves IB degradation, is involved in caerulein-
stimulated pancreatic acinar cells. Another important transcription factor, AP-1, was 
found to have a dose-dependent activation pattern similar to that of NF-B activation.  
We also looked at the possible relationship between the intracellular kinases 
(ERK and JNK) and the transcription factors (NF-B and AP-1). JNK is widely 
known to be an activator of AP-1 (Karin and Gallagher, 2005), but other possible 
interactions between ERK, JNK, NF-B and AP-1 are poorly understood. Kook et al. 
reported that inhibitors of ERK and JNK inhibited AP-1 DNA binding and c-Fos/c-
Jun activation in human periodontal ligament fibroblasts (Kook et al., 2009). Jiang et 
al. also showed an ERK dependent activation of NF-B in IL-1β induced rat vascular 
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smooth muscle cells (Jiang et al., 2004). In agreement with Ramnath et al, our results 
pointed as well to an ERK/JNK-dependent activation of NF-B and AP-1 in 
pancreatic acinar cells (Ramnath et al., 2007). We demonstrated that administration of 
PD98059 and SP600125 significantly inhibited both NF-B p65 subunit and AP-1 
DNA binding activity in caerulein stimulated pancreatic acinar cells. These 
observations suggest a possible role of MAPKs in regulating the nuclear translocation 
that lead to the activity of NF-B p65 subunit and AP-1 during stimulation by 
caerulein. Our results also add to the growing evidence about MAPKs in regulating 
the activity of NF-B and AP-1 (Kundu et al., 2006; Bladh et al., 2009). 
NF-B is generally known to control the expression of numerous 
inflammatory mediators. We used an irreversible inhibitor of IB phosphorylation, 
Bay 11-7082 to investigate the role of NF-B in caerulein-stimulated SP/NK1R up-
regulation. Our results showed directly that NF-B is involved in the transcription of 
NK1R and PPTA, as inhibition of NF-B by Bay 11-7082 abolished the up-regulation 
of these products. The increased transcription of PPTA is probably contributed to the 
increased expression of SP. These observations were in agreement with the results 
done on other models, which also highlighted the involvement of NF-B activation in 
the increased expression of PPTA and NK1R (Guo et al., 2004; Reed et al., 2005; 
Corcoran and Rameshwar, 2007).   
Our results had shown that inhibition of ERK phosphorylation by PD98059 
caused inhibition of DNA binding activity of NF-B. Interestingly, pre-treatment 
with NF-B inhibitor Bay 11-7082, but not ERK inhibitor PD98059, inhibited the up-
regulation of PPTA and SP in caerulein stimulated pancreatic acinar cells. These 
results suggest that the up-regulation of PPTA and SP is independent of ERK 
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activation, but might be dependent on NF-B activation. This may seem inconsistent, 
but we should take into consideration that it is still unclear how the activation of ERK 
lead to the activation of NF-B. It is possible that when ERK is inactivated, an 
alternative mechanism is available to maintain the high expression of PPTA and SP in 
caerulein stimulated pancreatic acinar cells. Another possibility that Bay 11-7082 
may have non-specific effects in our caerulein model. Thus, we have found that AP-1 
DNA binding ability was inhibited when high concentrations of Bay 11-7082 were 
used (Data not shown). Therefore, there is a possibility that AP-1, but not NF-B, is 
involved in the up-regulation of PPTA and SP. This explanation requires further 
confirmation as there is little evidence to challenge the specificity of Bay 11-7082. 
On the contrary, the ERK dependent NF-B activation is probably involved in 
mediating the gene expression of NK1R, as inhibition of ERK by PD98059, as well as 
inhibition of NF-B activation by Bay 11-7082, reversed the up-regulation of NK1R 
mRNA expression.  
In the second part of this chapter, we investigate the role of PKCs on 
caerulein-mediated SP/NK1R expression in murine pancreatic acinar cells.  
We first identified that both PKC and PKC are activated in a time 
dependent manner during supramaximal caerulein exposure. This is shown by a rapid 
phosphorylation at key activation sites of the molecule. The phosphorylation of 
PKC is transient, as we observed a decrease of phosphorylation around 60 minutes 
of caerulein treatment, when compared with earlier time points. Caerulein has 
previously been shown to activate PKC for various cellular responses in pancreatic 
acinar cells. However, the activation of PKC is still not clear in high concentrations 
of CCK/caerulein used. Satoh et al. did not observe increased PKC translocation to 
 82 
  
the membrane after 30 minutes of supramaximal CCK stimulation (Satoh et al., 2004). 
On the other hand, Cosen-Binker et al. found significant increase in PKC activity 
after treating pancreatic acinar cells with CCK (Cosen-Binker et al., 2007).  Previous 
studies have shown an excessive rise in Ca
2+
 levels in caerulein-induced pancreatic 
acinar cells (Okada et al., 1998).  Therefore, the Ca
2+ 
dependent activation of PKC is 
very likely to occur. The different incubation time, animal strain used, or detection 
methods might explain discrepancies between studies, and further investigation will 
be needed to address the issue.  
In order to differentiate the role of PKC and PKC in caerulein stimulated 
cells, we employed the use of isozyme specific pharmacological inhibitors. Gö6976 
(IC50=2.3nM) is a Ca
2+
 dependent PKC isozyme inhibitor, and therefore it was used 
to block the actions of PKC in our study (Martiny-Baron et al., 1993). Rottlerin 
(IC50=3M) has some selectivity towards PKC and is widely used to investigate the 
cellular mechanisms mediated by PKC(Gschwendt et al., 1994; Li et al., 2004; 
Ramnath et al., 2008). In an attempt to avoid cross-inhibition of PKC and PKC, we 
tested the inhibitors with reference to the reported IC50 values. The efficacy and 
specificity of the two inhibitors was tested and confirmed in our results. Gö6976 
showed some inhibition of PKC at a concentration of 1nM and further inhibited 
PKC phosphorylation when the concentration was increased to 10nM. On the other 
hand, rottlerin showed a complete inhibition of PKC phosphorylation when a 
concentration of 1-10M was used. At these concentrations used, Gö6976 and 
rottlerin did not significantly block the other form of studied PKC. This could then be 
applied to differentiate the role of conventional PKC and novel PKC in caerulein-
induced SP/NK1R up-regulation in our model. Despite the specificity shown in PKC 
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inhibition, rottlerin has also recently been shown to affect several PKC-independent 
mechanisms, mostly related to mitochondrial uncoupling pathway (Soltoff, 2001; 
Tapia et al., 2006). Therefore, it is important to control the concentration of rottlerin 
used and caution exercised when interpreting the results.   
We then employed the use of selective PKC inhibitor Gö6976, and selective 
PKC inhibitor rottlerin, to observe the role of PKCs on SP/NK1R expression. Our 
data indicated that pre-treatment with either Gö6976 or rottlerin significantly 
attenuated caerulein-induced SP up-regulation. Furthermore, real time PCR analysis 
revealed that mRNA expression of PPTA was significantly reduced with Gö6976 or 
rottlerin pre-treatment. Studies done on NK1R expression also showed similar results 
that pre-treatment of pancreatic acinar cells with either Gö6976 or rottlerin 
significantly attenuated NK1R mRNA and protein expression. The concentration of 
Gö6976 and rottlerin required to reverse SP and NK1R up-regulation was also in line 
with the concentration required to inhibit phosphorylation of PKC and PKC. These 
observations suggested that the PKCs play a role in mediating the gene expression of 
PPTA and NK1R, which in turn cause an increase in protein expression of SP and 
NK1R in the mouse pancreatic acinar cells. Overall, our data showed that activation 
of both conventional PKC and novel PKC is equally important in caerulein-
induced SP/NK1R up-regulation in the mouse pancreatic acinar cells.  
Evidence from several models demonstrated the relationships between PKCs 
and MAPKs in the expression of genes. Some suggested that the PKC family, as a 
whole, activate the MAPK pathway (Lin et al., 2009); while many others attempted to 
identify the role of individual PKC isoforms in the activation of MAPKs (Yoshida et 
al., 2002; Cheng et al., 2009). There is also evidence that MAPKs is activated by 
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more than one PKC isoforms. Sun et al. suggested in a macrophage cell line that SP 
induced ERK phosphorylation via activation of both PKCPKC and PKC(Sun et 
al., 2009)Therefore, there is still much unknown regarding the role of individual 
PKC isoforms in the activation of MAPKs. In this current study, we used the 
inhibitors that had been shown to inhibit SP and NK1R to investigate its effect on 
ERK and JNK activation. We found that pretreatment with Gö6976 or rottlerin 
significantly attenuated caerulein-induced JNK and ERK phosphorylation, showing 
that PKC and PKC are up-stream of the MAPKs. Our results were consistent with 
the findings that rottlerin treatment affected the phosphorylation of JNK and ERK in 
SP-treated mouse pancreatic acinar cells (Ramnath et al., 2008). Gö6976 or rottlerin 
treatment was also found to inhibit renin receptor expression and osteoclastogenesis 
via the PKC-MAPK pathways (Huang and Siragy; Tiedemann et al., 2009). We also 
noticed that there is a consistent, but insignificant decrease of JNK phosphorylation 
with rottlerin pre-treatment. This could be due to baseline phosphatase activity, which 
dephosphorylates JNK when PKC kinase activity is inhibited by the drug.  
In pancreatic acinar cells, it was suggested that stimulation of CCK receptors 
could modulate gene expression via activation of several transcription factors, such as 
NF-B and AP-1 (Orlichenko et al.; Gukovsky et al., 2003). We have also shown that 
caerulein induced up-regulation of SP and NK1R expression was mediated via 
activation of ERK and JNK, followed by transcription factors NF-B and AP-1 (Koh 
et al., 2010). In this study, we found that PKC and PKC activation is necessary for 
the activation of MAPKs, and therefore it is logical to speculate that PKCs are located 
upstream of NF-B and AP-1. Both Gö6976 and rottlerin has been shown frequently 
to inhibit the activation of NF-B and AP-1 in various models (Bhatt et al.; Langlet et 
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al.; Kontny et al., 2000; Shin et al., 2007). However, there are reports suggesting 
PKC-independent activation of NF-B (Meichle et al., 1990; Shames et al., 1999) . 
Results from a study from Holden et al. suggested that the conflicting results 
observed could be due to different stimulating agents used. In that report, PKC 
activation was not involved in tumor necrosis factor- (TNF) induced NF-B 
activation, whereas phorbol 12-myristate 13-acetate (PMA) induced NF-B activation 
was found to require the activation of novel PKCs in pulmonary A549 cells (Holden 
et al., 2008). Our data showed that cells pre-treated with Gö6976 or rottlerin 
significantly inhibited caerulein stimulated increase of NF-B and AP-1 DNA 
binding activity. Due to the relatively small changes in NF-B DNA binding activity 
observed, we verified the activation of NF-B by checking the phosphorylation of 
IB, which is an important step for removing the inhibition of NF-B translocation 
into the nucleus. Western blot results of IB phosphorylation showed significant 
results with a greater magnitude, while maintaining a similar response pattern with 
NF-B DNA binding activity. Therefore, we suggest caerulein-induced PKC and 
PKC activation is necessary for the activity of NF-B and AP-1, which in turn 
required for SP and NK1R up-regulation.  
Taken together, the results presented in this chapter demonstrated several key 
elements leading to the up-regulation of SP and NK1R in the mouse pancreatic acinar 
cells. Caerulein activates both PKC and PKC, which in turn activated ERK and 
JNK, followed by an increased transcriptional activity of NF-B and AP-1. These 
mechanisms eventually lead to the increased expression of SP and NK1R at both 
genetic and protein levels (Figure 3.14, 3.15). Overall, we did not find a difference in 
the role of conventional PKC and novel PKC, as activation of both molecules are 
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necessary for the cellular responses observed. These results provide a clearer picture 
on the mechanisms that lead to up-regulation of SP and NK1R; thus providing the 





Figure 3.14 A schematic illustration of caerulein-induced up-regulation of SP in 






Figure 3.15 A schematic illustration of caerulein-induced up-regulation of NK1R in 













CHAPTER 4: ACTIVATION OF NEUROKININ-1 RECEPTORS 
UP-REGULATES SUBSTANCE P AND NEUROKININ-1 
RECEPTOR EXPRESSION IN MURINE PANCREATIC ACINAR 
CELLS  
 
Originally published in Journal of cellular and molecular medicine.  
Yung-Hua Koh, Shabbir Moochhala, and Madhav Bhatia. Activation of neurokinin-1 
receptors up-regulates substance P and neurokinin-1 receptor expression in murine 







Although the importance of SP-NK1R interaction in AP and other 
inflammatory diseases has been brought into focus, mechanisms that regulate their 
expression were less explored. The expression of both SP and NK1R were shown to 
be up-regulated in the pancreas and lung in caerulein-induced AP (Bhatia et al., 1998). 
Similar up-regulation was observed when isolated mouse pancreatic acinar cells were 
incubated with caerulein (10
-7
M). In a previous study, antagonism of NK1R with 
CP96,345 significantly reversed AP-induced PPTA/NK1R mRNA up-regulation in the 
pancreas (Lau and Bhatia, 2006). In other words, NK1R activation might be involved 
in SP/NK1R expression in mice. This observation hinted the possibility of an auto-
regulatory mechanism in the pancreas, where activation of NK1R contributed to the 
overall elevated expression of SP and NK1R.   
In chapter 2 and 3, we have recently demonstrated that treatment of mouse 
pancreatic acinar cells with caerulein induced SP/NK1R up-regulation via activation 
of CCKA receptors. The response is rapid, with a significant up-regulation occurring 
within one hour of stimulation. Activation of CCKA receptors causes subsequent PKC 
– MAPK – NF-B/AP-1 activation, and leads to up-regulation of SP and NK1R 
expression. On the other hand, activation of NK1R is also known to activate similar 
pathways via its G-protein coupled downstream signaling (Ramnath et al., 2008). In 
mouse pancreatic acinar cells, it was shown that treatment of cells with SP up-
regulated chemokine expression by a Src-Ca
2+
-PKC-MAPK-NF-B dependent 
pathway (Ramnath et al., 2009). Hence, there are similarities between NK1R and 
CCKA receptors with regard to their downstream signaling pathways  
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In this chapter, we aim to examine the relationship between exposure to SP 
and the expression of SP and NK1R in isolated mouse pancreatic acinar cells. We 
assessed both protein and mRNA expression levels of SP and NK1R after pancreatic 
acinar cells were treated with SP or a selective NK1R agonist, GR73,632.  In some 
experiments, we used CP96,345, a selective NK1R antagonist, or  specific inhibitors 
of signaling molecules to elucidate the signaling pathway involved. Finally, we also 
compared the differences between SP-mediated responses with caerulein-mediated 
responses. 
4.2 MATERIALS AND METHODS 
 
4.2.1 Animals and chemicals.  
Refer to section 2.2.1. Swiss mice (Male, 25-30 grams) were used for isolation 
of pancreatic acinar cells. PD98059 (Mitogen-activated protein kinase kinase (MEK) 
inhibitor), SP600125 (JNK inhibitor), Bay11-7082 (NF-B inhibitor), Gö6976 
(PKC/ inhibitor) and rottlerin (PKC inhibitor), were purchased from Calbiochem 
(Darmstadt, Germany). CP96,345 (selective NK1R antagonist) and GR73,632 
(selective NK1R agonist) was obtained from Sigma-Aldrich (Singapore). They were 
all dissolved in DMSO. SP and caerulein was purchased from Bachem (Torrance, CA) 
and dissolved in normal saline.  All chemicals were purchased with the highest purity 
available.   
4.2.2 Preparation and treatment of pancreatic acinar cells.  









M). The concentration 
of caerulein and SP used in this study was shown to activate NF-B dependent gene 
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expression in pancreatic acinar cells (Ramnath and Bhatia, 2006; Koh et al., 2010). 
For time-dependent studies, cells were treated with caerulein or SP for 30, 60, 90, 120 
minutes in a 37ºC water bath. For other experiments, cells were pre-treated with 
either Gö6976 (10nM), rottlerin (5M), PD98059 (30M), SP600125 (30M), 
Bay11-7082 (30M), or CP96,345 for 30 minutes before addition of caerulein, SP or 
GR73,632 (10
-7
M). The concentration of these inhibitors was previously established 
and showed to be effective in caerulein-treated pancreatic acinar cells (Chapter 3). 
Gö6976, rottlerin, PD98059, SP600125, Bay11-7082, and CP96,345 were dissolved 
in dimethyl sulfoxide (DMSO) and diluted with buffer A. The final concentration of 
DMSO in the cell culture is less than 1 percent. Other chemicals were dissolved in 
normal saline and diluted with buffer A.  
4.2.3 Substance P extraction and detection.  
 Refer to section 2.2.4.  
4.2.4 RNA isolation and quantitative real time PCR analysis.  
Refer to section 2.2.6 and 2.2.8 
4.2.5 Whole cell lysate preparation and Western blot analysis.   
Refer to section 2.2.9.  
4.2.6 Statistical analysis.  





4.3.1 Substance P induces PPTA and NK1R mRNA expression in murine 
pancreatic acinar cells  
In order to understand the role of SP-NK1R interaction in SP/NK1R 
expression, we first examine the effect of exogenous SP on PPTA/NK1R mRNA 
expression in pancreatic acinar cells. As we have showed that PPTA and NK1R 
mRNA expression could be induced by caerulein (Chapter 2), gene expression levels 
of caerulein-induced cells were compared alongside with SP induced-cells.  To do 





M) for up to 120 minutesAfter incubation of cells with SP, both PPTA 
and NK1R mRNA expression showed a time-dependant increase, as determined by 
real-time PCR assay. Expression levels start to rise significantly after 30 minutes, and 
peaked in 1-2 hours after treatment with SP (Figure 4.1A, 4.1B). In comparison, both 
SP-induced cells and caerulein-induced cells showed a similar 2-fold increase of 
PPTA mRNA expression (Figure 4.1A). On the other hand, NK1R expression in SP-
treated cells (1.6 fold increase) was considerably lower when compared to caerulein-
treated cells (2.5 fold increase) (Figure 4.1B).  In our studies, mRNA expression of -
actin, which was used as a housekeeping gene, showed no significant changes in 





Figure 4.1 SP induced gene expression of PPTA and NK1R in murine pancreatic 
acinar cells. Freshly prepared pancreatic acinar cells were treated with either SP (10-
6
M) or Cae (10
-7
M) for 0-120 minutes. PPTA/NK1R mRNA expression was 
determined with real time PCR following TRIzol reagent extraction and normalized 
with -actin expression in the samples.  (A) Time course effect of SP and caerulein 
treatments on PPTA mRNA expression. (B) Time course effect of SP and caerulein 
treatments on NK1R mRNA expression. Results are expressed as means ± SEM from 
4-6 independent experiments. *P<0.05, vs. control.   
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4.3.2 CP96,345 down-regulates exogenous SP-induced PPTA and NK1R mRNA 
expression  
We have previously shown that SP up-regulated the expression of PPTA and 
NK1R in pancreatic acinar cells. To test whether this effect is due to SP-NK1R 
interaction, we pre-treated cells with CP96,345, a selective NK1R antagonist, before 
induction with SP (Snider et al., 1991). Pre-treatment of cells with CP96,345 
inhibited PPTA and NK1R mRNA expression in a concentration dependent manner, 
when compared to their vehicle treated SP-induced cells. At a low concentration of 
0.2M, CP96,345 started to show minor inhibitory effect but at higher concentrations 
(5M), it completely abolished SP-induced up-regulation of PPTA/NK1R mRNA 
expression (Figure 4.2A, 4.2B). Treatment of CP96,345 in the absence of SP did not 
alter expression levels when compared to the baseline control (data not shown), 
suggesting that NK1R activation is not involved in maintaining the basal expression 




4.3.3 Caerulein induced PPTA and NK1R gene expression in murine pancreatic 
acinar cells does not involve the activation of NK1R 
Previous results have demonstrated an increase in PPTA and NK1R mRNA 
expression in the pancreas when mice were induced with AP. On the other hand, 
antagonism of NK1R with CP96,345 significantly reduced their expression (Lau and 
Bhatia, 2006). This suggested that activation of NK1R partly attributed to the overall 
PPTA/NK1R up-regulation observed in caerulein-treated animals. We aim to 
reproduce this observation in our cellular model of isolated pancreatic acinar cells. To 
do this, cells were treated with CP96,345 (1M) for 30 minutes before treatment with 
stimulatory concentration of caerulein (10
-7
M). Caerulein treatment significantly 
increased the expression of PPTA and NK1R. However, contrary to the animal model 
of caerulein-induced AP, antagonism of NK1R did not reduce mRNA expression of 






Figure 4.2 SP-induced, but not caerulein-induced PPTA/NK1R up-regulation is 
abolished by antagonism of NK1R. Pancreatic acinar cells were pre-treated with 
CP96,345 (0.2 – 5M) for 30 minutes before treatment with caerulein (10-7M) or SP 
(10
-6
M) for 60 minutes. Subsequently, PPTA and NK1R mRNA expression was 
determined with real time PCR following TRIzol reagent extraction and normalized 
with -actin expression in the samples. (A) Pre-treatment of CP96,345 reversed SP-
induced, but not caerulein-induced PPTA upregulation. (B) Pre-treatment of 
CP96,345 reversed SP-induced, but not caerulein-induced NK1R up-regulation. 
Results are expressed as the means ± SE from 6 independent experiments. *P<0.05 vs. 




4.3.4 Activation of NK1R induces expression levels of SP peptides 
Since PPTA and NK1R mRNA expression can be regulated through activation 
of NK1R, we further investigated SP peptide expression in pancreatic acinar cells. 
The presence of unlabelled exogenous SP was discovered to confound with 
endogenously produced SP using conventional ELISA assays (data not shown), and 
very likely with other protein assays. Therefore, we used a specific NK1R agonist, 
GR73,632,  to investigate its effects on SP peptide expression. GR73,632 had no 
detectable reactivity in the ELISA assay at concentrations up to 10g/ml. Isolated 





M). Our results showed that treatment of isolated murine pancreatic acinar 
cells with GR73,632 significantly increased SP peptide levels at concentrations larger 
than 10
-8
M (Figure 4.3A). To further confirm that the observations were mediated 
through NK1R, we treated cells with GR73,632 (1nM) and CP96,345 (1M). Pre-
treatment of CP96,345 completely abolished the effects of GR73,632, indicating that 





Figure 4.3 Activation of NK1R up-regulated SP peptide expression in isolated 





M) for 60 minutes. In some experiments, pancreatic 
acinar cells were pre-treated with CP96,345 (1M) before treatment with GR73,632 
(10
-7
M). SP peptide levels were determined using a commercially available ELISA 
kit and normalized with the DNA content of the samples. (A) Time course effect of 
SP and caerulein treatment on NK1R mRNA expression. (B) Time course effect of SP 
on NK1R protein expression. Results are expressed as means ± SEM from 4-6 




4.3.5 Effect of substance P treatment on protein expression of NK1R 
We also evaluated the effect of exogenous SP on NK1R protein expression. 
To do this, we performed a time course study of NK1R via Western blot. Using a 
specific antibody against NK1R, we found that cells cultured in control medium did 
not show a change in background expression of NK1R. On the other hand, a time-
dependant up-regulation of NK1R protein expression was observed in whole cell 
lysates after treatment with SP (Figure 4.4). After 2 hours of SP stimulation, NK1R 
band intensity reached a peak of 2.5-fold increase when compared to the control. 
 
Figure 4.4 SP up-regulates NK1R protein expression in a time dependent manner. 
Freshly prepared pancreatic acinar cells were treated with SP for 0-120 minutes. After 
treatment, whole cell lysates were prepared and 50g of protein were subjected to 
Western blot analysis. NK1R protein expression was normalized with HPRT 
expression in the samples. Results are expressed as means ± SEM from 4-6 
independent experiments. *p<0.05, vs. control.   
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4.3.6 SP up-regulates SP and NK1R expression via PKC, MAPK, and NF-B 
dependant pathways 
It was previously demonstrated that SP induces the expression of chemokines 
via the Src family kinases (Sfk) – ERK/JNK – NF-B pathway in pancreatic acinar 
cells (Ramnath et al., 2009). The  PKC family was also found to be activated after 
cells were stimulated with SP (Ramnath et al., 2008). These activated signaling 
molecules share similarities with the PKC-MAPK-NF-B pathway involved in 
caerulein-mediated responses (Chapter 2 and 3). To determine the signaling pathway 
in SP-induced expression of SP/NK1R, pancreatic acinar cells were pre-treated with 
specific inhibitors of PKCGö6976, 10nM), PKCRottlerin, 5M), MEK/ERK 
pathway (PD98059, 30M), JNK (SP600125, 30M), or NF-B (Bay11-7082, 30M) 
before induction with SP (10
-6
M, 60 minutes). The addition of these inhibitors almost 
completely abolished SP-induced PPTA/NK1R mRNA up-regulation in the pancreatic 
acinar cells (Figure 4.5A, 4.6A). Protein expression of SP and NK1R was also 
abrogated by the addition of PKC, MAPK or NF-B inhibitors (Figure 4.5B, 4.6B). 
These results confirm the similarity in downstream signaling pathways between 





Figure 4.5 PKC, MAPK, and NF-B are involved in SP induced SP up-regulation in 
murine pancreatic acinar cells. Freshly prepared pancreatic acinar cells were 
pretreated with either Gö6976 (10nM), rottlerin (5M), PD98059 (30M), SP600125 
(30M), or Bay11-7082(30M) for 30 minutes before stimulation with SP (10-6M) or 
GR73,632(10
-7
M) for 60 minutes. PPTA expression was determined with real time 
PCR and SP levels were determined by a commercially available ELISA kit. PPTA 
mRNA expression was normalized with -actin expression and SP levels was 
normalized with DNA content in the samples.  Results are expressed as means ± SEM 
from 4-6 independent experiments. *p<0.05 vs. control, #p<0.05 vs. SP/GR73,632 




Figure 4.6 PKC, MAPK, and NF-B are involved in SP induced NK1R up-regulation 
in murine pancreatic acinar cells.  Freshly prepared pancreatic acinar cells were 
pretreated with either Gö6976 (10nM), rottlerin (5M), PD98059 (30M), SP600125 
(30M), or Bay11-7082(30M) for 30 minutes before stimulation with SP (10-6M for 
60 minutes. NK1R mRNA expression was determined with real time PCR. Whole cell 
lysates were prepared and 50g of protein subjected to Western blot analysis of 
NK1R and HPRT. NK1R mRNA expression was normalized with -actin expression 
and NK1R protein expression was normalized with HPRT expression.  *p<0.05 vs. 





SP-NK1R interaction was defined as a pro-inflammatory process that 
contributes to the progression of AP (Bhatia et al., 1998; Liddle and Nathan, 2004). 
Both pancreatic SP and NK1R expression are elevated in caerulein-induced AP 
models. We have previously reported caerulein-induced expression of SP and NK1R 
in isolated mouse pancreatic acinar cells and the mechanisms that led to their up-
regulation (Koh et al., 2010; Koh et al., 2011). In the present study, we sought to 
investigate the effect of SP on the expression of SP and NK1R in isolated pancreatic 
acinar cells.  
Herein we demonstrated that SP treatment increased PPTA and NK1R mRNA 
expression in isolated murine pancreatic acinar cells. We observed that the response 
was rapid, with significant up-regulations occurred within one hour after 
administration of SP. This is in agreement with previous studies, which also showed 
rapid increases in chemokine expression when pancreatic acinar cells were stimulated 
with SP (10
-6
M) (Ramnath and Bhatia, 2006). SP treatment also induced a gradual 
increase in protein levels of NK1R. These rapid changes might enhance SP-NK1R 
dependent pro-inflammatory responses in early phase of AP. SP was widely reported 
to act through stimulation of NK1R, including isolated pancreatic acinar cells 
(Ramnath and Bhatia, 2006). Pre-treatment of cells with the selective NK1R 
antagonist CP96,345 completely reversed SP-induced up-regulation of PPTA and 
NK1R mRNA expression. Therefore, we suggest the observations were dependent on 
the activation of NK1R. These results proposed the presence of an “auto-regulatory” 
mechanism, in which activation of NK1R increases the expression of SP and NK1R, 
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thus potentially creating a positive feedback loop. However, the occurrence and 
extent of this feedback loop is currently unclear in physiological conditions.  
GR73,632, a specific agonist of NK1R, induced a concentration-dependant 
increase of endogenous SP levels. Concurrent treatment of cells with an agonist and 
antagonist of NK1R completely abrogated the effects of NK1R activation. These 
observations confirmed that GR73,632 acts specifically through NK1R, and further 
demonstrated that NK1R activation is one possible mechanism that contribute to 
increased SP levels. The EC50 of GR73,632 was published as 2nM in guinea pig vas 
deferens, but information on pancreatic acinar cells was not available (Hall and 
Morton, 1991). In agreement with previously published EC50 concentrations, our 
results showed that SP levels were induced with low nanomolar concentrations of 
GR73,632 . On the other hand, previous work showed that the addition of exogenous 
SP (10
-8
M) increased PPTA expression in cultured human normal fibroblasts (Bae et 
al., 2002). In light of these observations, the proposed self-perpetuating feedback loop 
might also occur at lower concentrations of SP depending on the cell type used. 
Our results have suggested that caerulein stimulated CCKA receptors and SP 
stimulated NK1R receptors in mouse pancreatic acinar cells. Current findings also 
suggested that CCKA and NK1R downstream signaling may involve a similar 
pathway. Upon stimulation with caerulein, both PPTA and NK1R gene were up-
regulated by a PKC-MAPK-NF-B dependent pathway in the pancreatic acinar cells. 
Ramnath et al also showed SP-induced chemokine expression via the activation of 
PKC, MAPK and NF-B pathway. These similarities are not surprising as both CCKA 
receptors and SP receptors are both G-protein coupled receptors, acting via Gq/11 
pathways (Khawaja and Rogers, 1996; Williams, 2001). In reference to previously 
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established effective concentrations, pre-treatment of cells with specific inhibitors of 
PKC, ERK/JNK, and NF-B abolished SP-induced up-regulation of SP/NK1R in 
both protein and mRNA levels. In this case, activation of NK1R may lead to the 
activation of PKC and subsequent MAPK activation, followed by NF-B 
transcription factor activation, which ultimately up-regulated expression of SP and 
NK1R (Figure 4.7). The role of MAPKs on the activation of NF-B is poorly 
understood, but current evidence suggest that ERK/JNK could act upstream of NF-B 
by modulating IB or IB kinase (Chen and Lin, 2001; Lin et al., 2005; Cheng et al., 
2009). Despite these observations, the similarities in CCKA signaling pathway and 
NK1R signaling pathway should not be extrapolated to other models, as they exhibit 
very different responses in physiological conditions.  
Previous studies have hinted the presence of an auto-regulatory mechanism of 
SP/NK1R expression in AP. In the pancreas of caerulein-treated mice, up-regulation 
of PPTA and NK1R mRNA expression was partially abolished when they were pre-
treated with a selective NK1R antagonist, CP96,345 (Lau and Bhatia, 2006). This is 
interesting because caerulein is not known to mediate through NK1R. Hence, we 
investigated whether similar observations could be reproduced in isolated pancreatic 
acinar cells. Unfortunately, CP96,345 neither reduced nor raised caerulein-induced 
up-regulation of PPTA/NK1R expression in these cells. Therefore, caerulein itself has 
no direct effects on the NK1R receptors. The difference between animal model and 
cellular model setting might be attributed to additional SP sources in vivo. SP can be 
released by nerve endings and also by infiltrating leukocytes, increasing its local 
levels so high that enabled the activation of NK1R to induce SP/NK1R up-regulation 
in pancreatic acinar cells. On the other hand, SP produced in pancreatic acinar cells 
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alone did not reach sufficient concentrations to trigger stimulatory effects on the 
NK1R in our design.  
Autocrine regulation of SP and NK1R may have its significance in regulating 
the severity of AP and other inflammatory diseases. In immune cells, autocrine 
regulation of SP was suggested to be involved in T-lymphocyte proliferation 
(Lambrecht et al., 1999). During intestinal inflammation, it was suggested that 
autocrine/paracrine regulation of cytokine secretion by SP lead to a worsening of 
inflammation conditions (Castagliuolo et al., 1997). Besides involvement in 
inflammatory conditions, SP auto-regulation was also shown in other physiological 
functions. In one previous report, exogenously administered SP in sutured rat Achilles 
tendon rupture had a booster effect on endogenous SP for fibroblast proliferation via 
autocrine/paracrine stimulation (Steyaert et al., 2010). With SP currently known to 
promote chemokine production in macrophages and pancreatic acinar cells, this auto-
regulatory mechanism might be of significance. Especially when pancreatic acinar 
cells consisted of the bulk of pancreatic mass, SP contributed by these cells cannot be 
discounted. Further work could be done to elucidate the occurrence and extent of this 
auto-regulatory effect during the course of AP.  
The observation that activation of NK1R up-regulates the expression of SP 
and/or NK1R is very likely to depend on the cell type or model used. SP was found to 
cause a 13-fold increase in PPTA expression in human mononuclear phagocytes (Lai 
et al., 2002). Continuous administration of thiorphan, a specific neutral endopeptidase 
inhibitor, reduced SP degradation and enhanced rat thymocyte PPTA and NK1R 
mRNA expression as well as SP and NK1R protein levels in an NK1R-dependent 
manner (Amantini et al., 2008). It was also previously shown that stem cell factor 
treatment on bone marrow stroma induced PPTA and NK1R expression leading to 
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autocrine and/or paracrine cell activation (Qian et al., 2001). Previous studies has also 
shown direct evidence of an auto-regulatory role of SP/NK1R expression in human 
keratinocytes and human mononuclear phagocytes (Bae et al., 1999; Bae et al., 2002). 
The auto-regulatory mechanism could also be activated by a N-terminal metabolite of 
SP. In that study, only NK1R expression, but not SP expression, was up-regulated by 
treatment of a SP metabolite on rat spinal cord (Velazquez et al., 2002). Although 
there was evidence to suggest an auto-regulatory role of SP and NK1R expression, 
there were also several reports that showed otherwise. Hegde et al. showed that 
treatment of mice with SR140333, a selective NK1R antagonist, did not abolish 
sepsis-induced SP up-regulation in the lung (Hegde et al., 2010). Even in caerulein-
induced AP model itself, it was shown that lung NK1R expression was further up-
regulated when mice were treated with CP96,345, suggesting antagonism of NK1R 
further enhanced NK1R expression (Lau and Bhatia, 2006). Palmer et al. also 
reported that disruption of the NK1R gene does not prevent up-regulation of PPTA 
mRNA in the spinal cord of mice following peripheral inflammation, when SP levels 
was greatly up-regulated (Palmer et al., 1999). Therefore, much work needs to be 
done to elucidate the different mechanisms that regulate SP/NK1R expression in 
different cell types. Investigators should be cautious when extrapolating the results to 
all models.  
Collectively, the results presented in this chapter describe a novel mechanism 
of the contribution of SP-NK1R interaction during AP. Auto-regulation of SP/NK1R 
expression was occasionally reported but it has not been brought to focus. Current 
knowledge suggests that the SP increase in the pancreas could be contributed to 
increased release from sensory nerve fibers, infiltrating leukocytes, and possibly from 
the pancreatic acinar cells. Together, these sources contribute to elevated SP levels 
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and up-regulate the expression of cytokines and chemokines via activating the NF-B 
pathway. Further work could be done to investigate the contribution of each of these 
sources of SP and defining other mechanisms that lead to SP/NK1R up-regulation. It 
is also useful to study the expression of SP/NK1R in peripheral neurons following 
NK1R activation, as they were considered to be a major source of endogenously 
produced SP.  
In conclusion, we report evidence for the auto-regulatory mechanisms of SP 
and NK1R expression. By activation of the NK1R receptors, it is possible to up-
regulate the expression of SP and NK1R in a PKC-MAPK-NF-B dependant pathway 
(Figure 4.7). With further understanding on the mechanisms that modulate 
physiological SP levels, new approaches may be achieved for the management of AP 




Figure 4.7 A schematic model summarizing the results of the chapter 4. The auto-
regulatory effect of SP/NK1R expression could potentially elevate their expression to 
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Increased expression of SP in SP-expressing cells and increased release of SP 
from nerve endings are two mechanisms that may contribute to elevated SP levels in 
experimental AP. In chapters 2 to 4, we have shown that both caerulein and SP are 
able to induce the expression of SP/NK1R in murine pancreatic acinar cells. However, 
inhibitory mechanisms that terminate the effect of SP were not clearly understood. 
Neutral endopeptidase (NEP) is a protease known to be capable of modulating 
inflammatory responses by degradation of SP (Sturiale et al., 1999; Scholzen et al., 
2001). In a model of experimental colitis, knockout of the NEP gene increased SP 
levels in the colon and exacerbates inflammation (Sturiale et al., 1999). On the other 
hand, treatment of exogenous recombinant NEP protected animals against intestinal 
inflammation and burns (Neely et al., 1996; Sturiale et al., 1999; Kirkwood et al., 
2001). These reports clearly show an anti-inflammatory role of NEP, possibly via the 
degradation of SP.     
 To date, the role of NEP in the pathogenesis of AP is not thoroughly 
understood. Genetic deletion of NEP exacerbated lung injury and greatly increased 
mortality rate in CDE-diet induced AP (Maa et al., 2000b). NEP is also a determinant 
of pancreatic elastase associated lung injury. Mice pre-treated with phosphoramidon, 
a NEP inhibitor, showed significant elevations in lung myeloperoxidase (MPO) levels 
and worsened lung histology compared to mice which did not receive 
phosphoramidon treatment (Day et al., 2005). In a similar model of pancreatic 
elastase-induced lung injury, treatment of mice with recombinant NEP ameliorates 
the detrimental effects of elastase (Lightner et al., 2002).  
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Despite an anti-inflammatory role of NEP in inflammation, physiological 
changes of NEP expression and activity in caerulein-induced AP are not known. 
Therefore, in the present study we investigated the potential regulatory role of 
caerulein on NEP activity and expression. Subsequently, NEP inhibitors and 
exogenous NEP were used to examine the effects of NEP on the outcome of AP. 
Although the primary focus of this chapter is on pancreatic injury, lung injury is often 
observed in severe AP (Maa et al., 2000b; Lau et al., 2005). Hence, lungs have also 
been investigated for pathological changes.  
 
5.2 MATERIALS AND METHODS 
 
5.2.1 Animals and chemicals. 
All experimental procedures were approved by the Animal Ethics Committee 
of the National University of Singapore and carried out in accordance with 
established International Guiding Principles for Animal Research. Balb/C mice (Male, 
20-25 grams) were acclimatized in a controlled environment with an ambient 
temperature of 23
o
C and a 12:12-hour light-dark cycle. Caerulein was purchased from 
Bachem (Torrance, CA) and dissolved in normal saline. Phosphoramidon and 
thiorphan (NEP inhibitors) was purchased from Sigma-Aldrich and dissolved in 
normal saline and 100% ethanol respectively. Recombinant mouse neutral 
endopeptidase was purchased from Sino-Biological (Beijing, China) and diluted in 
normal saline. Caerulein was purchased from Bachem.   
5.2.2 Preparation and treatment of pancreatic acinar cells.  
Refer to section 2.2.2. Freshly isolated pancreatic acinar cells were treated 
with caerulein (10
-7
M) for 0-120 minutes.  
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5.2.3 Induction of Acute pancreatitis.  
Balb/c mice were randomly assigned to control or experimental groups by 
using ten animals for each group. Animals were given hourly intraperitoneal 
injections of saline containing caerulein (50g/kg) for 3, 6, or 10 hours to induce mild, 
moderate, or severe AP respectively (in terms of relative severity of caerulein-induced 
models). Control mice received hourly normal saline injections. In order to 
investigate whether NEP inhibition exacerbates AP, mice received a pre-treatment of 
phosphoramidon (5mg/kg, i.v.) or thiorphan (10mg/kg, i.v.) 1 hour before 6 hourly 
caerulein injections. These concentrations were chosen in reference to previous 
studies (Buckner et al., 1991; Pollock et al., 1993). On the other hand, in order to 
investigate the protective effects of NEP, mice received 10 hourly caerulein injections 
and received post-treatment of recombinant mouse NEP (1mg/kg, i.v.) during the 2
nd
 
injection of caerulein. One hour after the last caerulein injection, animals were killed 
by a lethal dose of sodium pentobarbitone (150mg/kg, i.p.). Samples of pancreas, lung 
and blood were collected. Plasma was prepared from anti-coagulated blood samples 
by centrifugation (10,000g, 5 minutes, 4
o
C). Random cross sections of the head, body 
and tail of the pancreas and samples of the right lung were fixed in 10% neutral 
buffered formalin (Sigma-Aldrich). A small section of pancreas and lung was 
weighed and then dried for 72h at 55
o
C and reweighed to determine pancreatic water 
content. Remaining samples were then stored at -80
o
C for subsequent analysis.  
5.2.4 Measurement of myeloperoxidase activity.  
Neutrophil sequestration in the pancreas and lung was quantified by 
measuring tissue myeloperoxidase (MPO) activity. Tissue samples were thawed, 
homogenized in 20mM phosphate buffer (pH 7.4), centrifuged (13,000g, 10min, 4
o
C), 
and the resulting pellet was resuspended in 50mM phosphate buffer (pH 6.0) 
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containing 0.5% (w/v) hexadecyltrimethulammonium bromide (Sigma-Aldrich). The 
suspension was subjected to four cycles of freezing and thawing and was further 
disrupted by sonication (40s). The sample was then centrifuged (13,000g, 5min, 4
o
C) 
and the supernatant used for MPO assay. The reaction mixture consisted of the 
supernatant (50l), 1.6mM tetramethylbenzidine (KPL, MD), 80mM sodium 
phosphate buffer (pH 5.4), and 0.3mM hydrogen peroxide (Reagent volume: 50l). 
This mixture was incubated at 37
o
C and terminated with 50l of 0.18M H2SO4. The 
absorbance was measured at 450nm. This absorbance was then corrected for the DNA 
content of the tissue sample and results were expressed as fold change over control 
(Refer to section 2.2.5 for DNA assay).  
5.2.5 Histopathological examination.  
A small portion of pancreas was excised and fixed with 10% neutral buffered 
formalin (Sigma-Aldrich), dehydrated through a graded ethanol series, embedded in 
paraffin wax for routine histology. Sections of 5m thickness were stained with 
hematoxylin and eosin and examined by light microscopy using Nikon Eclipse 80i 
microscope (objective lens magnification x20; eyepiece magnification x10). 
5.2.6 ELISA analysis.  
ELISA assays were performed for the measurement of cytokines (interleukin-
1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor- (TNF-), chemokines 
(macrophage inflammatory protein-1 (MIP-1, macrophage inflammatory protein-
2 (MIP-2)) and adhesion molecules(intercellular adhesion molecule-1 (ICAM-1), 
vascular cell adhesion protein-1 (VCAM-1), p-selectin, e-selectin) in pancreas and 
lung tissue homogenates, according to manufacturer’s instructions (R&D systems, 
Minneapolis, MN). Results were then corrected for the DNA content of the tissue 
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homogenates and were expressed as picograms per microgram of DNA (Refer to 
section 2.2.5 for DNA assay). In this study, tissue content of DNA was chosen over 
tissue weight or tissue protein content as a normalization factor in ELISA analysis. In 
the pancreas, it has been shown that total DNA content (milligrams DNA per 
pancreas) remained relatively stable, but total protein content (milligrams protein per 
pancreas) was decreased in caerulein-induced pancreatitis models (Tani et al., 1987). 
Pancreatic edema in AP also alters the proportion of water in the tissue, which might 
cause bias when total pancreatic weight was used as a normalization factor. 
5.2.7 Measurement of NEP activity.  
NEP enzymatic activity was determined spectrophotometrically from 
extracted protein samples as described previously (Sio et al., 2010). Briefly, treated 
pancreatic acinar cells, pancreas and lung tissue was homogenized in T-PER tissue 
protein extraction reagent (Pierce, Rockford, IL) and centrifuged (12,000g, 15 
minutes, 4
o
C). Cell free extracts (30g protein) was incubated with 1mM succinyl-
Ala-Ala-Phe-p-nitroanilide (Suc-Ala-Ala-Phe-pNA; Bachem) as a substrate in 0.1 M 
Tris–HCl (pH 7.6) in the presence of 1 unit of porcine kidney aminopeptidase (AP-N; 
Sigma). In this coupled activity assay, NEP cleaves Suc-Ala-Ala-Phe-pNA between 
Ala and Phe, yielding Phe-pNA. AP-N subsequently cleaves Phe-pNA, generating 
pNA as the final product. The kinetic change in absorbance at 405nm due to the 
accumulation of free pNA was determined each minute at 37 °C for 60 min using a 
micro-plate reader. Substrate alone and substrate with AP-N and Tris buffer blanks 
were run in parallel. The rate of absorbance change were normalized with the control 
and expressed as fold change to control. Protein concentrations were determined by 
Bradford protein assay (Bradford, 1976).  
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5.2.8 Substance P extraction and detection.  
 Refer to section 2.2.4.  
5.2.9 RNA isolation and quantitative real time PCR analysis.  
Refer to section 2.2.6 and 2.2.8 
5.2.10 Whole cell lysate preparation and Western blot analysis.   
Refer to section 2.2.9. Cells were lysed with RIPA lysis buffer and protein 
concentrations were determined by Bradford protein assay. 50-80 µg of total cell 
lysate from each sample were subjected to Western blot analysis. The blots were 
incubated overnight with primary antibody of NEP (1:2000 dilutions) or HPRT 
(1:1000 dilutions). After washing away the primary antibodies, the membranes were 
incubated for 2 hours with goat anti-rabbit HRP-conjugated secondary antibody at 
1:2000 dilutions. Protein expression was then detected by adding SuperSignal™ West 
Pico chemiluminescent substrate before exposure to X-ray films. 
5.2.11 Statistical analysis.  






5.3.1 Caerulein suppress NEP activity and mRNA expression in isolated 
pancreatic acinar cells 
Pancreatic acinar cell NEP activity was significantly decreased as early as 30 
minutes after treatment with caerulein (10
-7
M), when compared to the control. A 
time-dependent decrease of NEP enzymatic activity was revealed, reaching a 
minimum after 2 hours of caerulein stimulation (Figure 5.1A). Moreover, NEP 
mRNA expression was significantly down-regulated in pancreatic acinar cells that 
were stimulated with caerulein for more than 60 minutes (Figure 5.1B). Cells that 
were incubated in control buffer did not show a significant change in both NEP 





Figure 5.1 Administration of caerulein decreased NEP activity and expression in 
pancreatic acinar cells. Freshly prepared pancreatic acinar cells were treated with 
caerulein (10
-7
M) for 0-120 minutes. (A) Time dependent decrease of NEP activity in 
pancreatic acinar cells. (B) NEP mRNA expression in pancreatic acinar cells. Values 
are means ± SEM; n=3-6 per time point.  *P<0.05 vs. control.   
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5.3.2 Caerulein-induced AP suppress endogenous NEP activity  
The suppression of NEP activity in caerulein-treated pancreatic acinar cells 
prompted us to investigate whether similar observations could be reproduced in 
animal models of AP. Balb/c mice were given hourly intraperitoneal injections of 
caerulein for 3, 6 or 10 hours to induce mild, moderate or severe AP respectively, in 
terms of relative severity. Caerulein-treated mice showed rapid decrease of pancreas 
NEP activity, with maximal suppression observed at severe AP conditions (Figure 
5.2A). Consistent with NEP activity results, Western blot analysis confirmed early 
and sustained decrease of NEP protein expression in the pancreas (Figure 5.2B). In 
the lungs, similar decreases of NEP activity and protein expression were observed 
after induction of AP (Figure 5.2C, 5.2D). Notably, protein expression of NEP in the 
lung showed a large magnitude of decrease, when compared to the control (Figure 









Figure 5.2 Administration of caerulein decreased NEP activity and expression in 
mice. Mice received hourly caerulein injections (50g/kg) and assessed for tissue 
NEP activity and expression.  (A) Pancreas NEP activity. (B) Pancreas NEP protein 
expression. (C) Lung NEP activity. (D) Lung NEP protein expression. Values are 
means ± SEM; n=10 mice per time point.  *P<0.05 vs. control.  
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5.3.3 Phosphoramidon and thiorphan increase SP levels in the pancreas, lung, 
and plasma. 
As NEP was previously shown to be protective against excessive 
inflammation, we anticipated that further suppression of NEP activity should 
exaggerate inflammatory conditions in AP. Therefore, we pre-inhibited NEP before 
induction of moderate AP, to investigate whether it would degenerate into a more 
severe form of AP. To do this, mice received a single dose of phosphoramidon 
(5mg/kg, i.v.) or thiorphan (10mg/kg, i.v.), followed by 6 hourly caerulein or saline 
injections. Both NEP inhibitors decreased NEP activity in the pancreas by 
approximately 70% one hour post-treatment (Data not shown). Control mice 
challenged with a single dose of phosphoramidon or thiorphan still showed a 20-30% 
reduction of NEP activity in the pancreas and lungs after 6 hourly saline injections, 
suggesting metabolism and drug clearance over time (Figure 5.3A, 5.3C). In contrast, 
SP levels rose significantly (Figure 5.3B, 5.3D). Induction of moderate AP 
suppressed NEP activity in both pancreas and lungs, coupled with a strong increase of 
SP in the pancreas and a modest but insignificant increase in the lungs (0.10>p>0.05). 
Interestingly, pre-treatment of NEP inhibitors followed by induction of AP provoked 
a further increase in SP levels (Figure 5.3B, 5.3D), but did not further reduce NEP 
activity (Figure 5.3A, 5.3C) in pancreas and lungs. Phosphoramidon or thiorphan 
administration did not alter background NEP activity in plasma, as NEP is a 
membrane-bound enzyme and not normally found in cell-free plasma (Figure 5.3E). 
Despite this, plasma SP concentrations were significantly elevated in all mice that 
received NEP inhibitor treatments, when compared to their respective untreated 












Figure 5.3 Inhibition of NEP by phosphoramidon and thiorphan decreased NEP 
activity and increased SP levels. Mice were randomly given phosphoramidon 
(5mg/kg. i.v.) or thiorphan (10mg/kg, i.v.) before 6 hourly injections of caerulein 
(50g/kg, i.p.) or normal saline. One hour after the last caerulein injection, mice were 
sacrificed and NEP activity and SP ELISA assays were performed as described in 
Materials and Methods. (A) Pancreas NEP activity. (B) Pancreas SP levels. (C) Lung 
NEP activity. (D) Lung SP levels. (E) Plasma NEP activity. (F) Plasma SP levels. 
Values are means ± SEM; n=10 mice per time point.  *P<0.05 vs. control.  
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5.3.4 Effect of NEP inhibition on plasma amylase activity, MPO activity, tissue 
water content and pancreatic histology 
After confirming that phosphoramidon and thiorphan elevated SP levels in 
mice, we assessed how NEP inhibition influences the outcome of AP. Amylase is 
produced in the pancreatic acinar cells and released into the bloodstream when there 
is a pancreatic injury, therefore it is often used clinically as a marker for diagnosis of 
AP. Another important feature of AP is an elevated MPO activity in the pancreas and 
lungs, indicating infiltration of neutrophils into these tissues (Bhatia et al., 1998). 
Inhibition of NEP without induction of AP did not alter basal plasma amylase activity, 
tissue water content or tissue MPO activity, despite elevated SP levels (Figure 5.4A-
E). On the other hand, NEP inhibitors further elevated plasma amylase activity, 
pancreas water content and pancreas MPO activity in AP-induced mice (Figure 5.4A-
5.4C). The lungs were less affected; as NEP inhibitors did not alter AP-induced 
increases in lung MPO activity and water content (Figure 5.4D, 5.4E). Histological 
examination of the pancreas confirmed that inhibition of NEP worsen damage in AP-
induced mice, characterized by increased pancreatic edema, neutrophil infiltration and 
pancreatic necrosis (Figure 5.5B, 5.5D, 5.5F). Normal pancreas architecture was 









Figure 5.4 Effect of NEP inhibition on plasma amylase activity, tissue MPO activity 
and tissue water content. Mice were randomly given phosphoramidon (5mg/kg. i.v.) 
or thiorphan (10mg/kg, i.v.) before 6 hourly injections of caerulein (50g/kg, i.p.) or 
normal saline. One hour after the last caerulein injection, mice were sacrificed and 
amylase activity, MPO activity, and water content measurement were performed as 
described in Materials and Methods. (A) Plasma amylase activity. (B) Pancreas MPO 
activity. (C) Pancreas water content. (D) Lung MPO activity. (E) Lung water content. 
Values are means ± SEM; n=10 mice per time point.  *P<0.05 vs. control, #P<0.05 vs. 




Figure 5.5 Histopathological evaluation (H&E staining) of pancreas 
polymorphonuclear leukocyte infiltration and injury. Formalin-fixed tissue sections 
were embedded in wax and cut into 5M sections.  (A) Control; (B) Mice received 6 
hourly caerulein (50g/kg) injections; (C) Mice received a single dose of 
phosphoramidon (5mg/kg) followed by saline injections. (D) Mice received a single 
dose of phosphoramidon (5mg/kg) followed by 6 hourly caerulein injections. (E) 
Mice received a single dose of thiorphan (10mg/kg) followed by saline injections. (F) 
Mice received a single dose of thiorphan (10mg/kg) followed by 6 hourly caerulein 
injections. (G) Mice received 10 hourly caerulein injections (H) Mice received a 
single dose of exogenous NEP (1mg/kg) and 10 hourly caerulein injections.  Scale 
bars = 0.1 mm.  
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5.3.5 Effect of NEP inhibition on pro-inflammatory cytokine, chemokine, and 
adhesion molecule expression 
Mice induced with moderate AP exhibited a significant elevation in pancreatic 
pro-inflammatory mediators which include cytokines (IL-1, IL-6, TNF-) and 
chemokines (MIP-1, MIP-2) (Table 5.1), compared with control mice which 
received saline injections. Adhesion molecule (ICAM-1, VCAM-1, p-selectin, e-
selectin) expression also showed modest increases, but they were not significantly 
different from the control. In the lungs, a milder up-regulation of pro-inflammatory 
mediators was observed, with only IL-1 and ICAM-1 significantly increased from 
control mice (Table 5.1b). Inhibition of NEP in AP-induced mice generally showed a 
further increase of pro-inflammatory mediator expression in both pancreas and the 
lungs, when compared to the control groups (Table 5.1a, 5.1b). NEP inhibitors alone 




Table 5.1 Effect of NEP inhibition on expression of cytokine, chemokine and 
adhesion molecules. Mice were randomly given phosphoramidon (Phos, 5 mg/kg. i.v.) 
or thiorphan (Thior, 10 mg/kg, i.v.) before six hourly injections of caerulein (Cae6h, 
50 mg/kg, i.p.) or normal saline. Tissue homogenates were subjected to ELISA assay 
and normalized with the DNA content of the homogenate and are expressed as 
picograms per microgram of DNA (n = 10 mice/group). *P <0.05 vs. control, 
#P<0.05 versus caerulein-treated mice. 
(a) Expression in pancreas 
 Control Cae6h Phos+C6h Thi+C6h Phos Thior 
IL-1  3.15±0.22 5.79±0.41* 6.41±0.37*  7.38±0.41*
,#
 4.35±0.29 3.93±0.36  
IL-6  4.08±0.27  5.98±0.61* 7.98±0.50*
,#
 7.74±0.63* 4.1±0.43 4.42±0.31 




 7.38±0.45 7.70±0.69 




 2.85±0.27 2.47±0.27 
MIP-2 4.11±0.24 6.36±0.58* 8.77±0.52*
,#
 6.68±0.50* 5.18±0.48 5.22±0.54 
E-Selectin 8.10±0.57  9.33±0.81 12.25±1.20* 11.12±1.08 10.19±0.94 7.87±0.97 
P-Selectin 26.36±1.99 31.15±3.52 43.55±4.63* 41.42±4.03* 33.42±2.28 26.60±3.19 
ICAM-1 33.96±3.11 41.42±3.05 48.39±5.69 52.51±5.28* 42.51±4.98 40.31±4.71 
VCAM-1 35.63±2.19 38.32±3.16 59.30±7.26* 48.49±5.49 35.49±2.46 38.07±4.48 
 
(b) Expression in lung 
 Control Cae6h Phos+C6h Thi+C6h Phos Thior 
IL-1  13.52±1.12 21.54±2.25* 20.04±2.52 18.21±1.52 12.81±1.65 13.42±1.31 
IL-6  11.91±0.53 13.57±2.05 14.07±1.40 12.34±1.36  9.78±1.44 11.21±1.49 
TNF- 10.00±0.94 16.34±2.49 20.94±1.84* 18.69±2.28* 13.17±2.28 15.50±2.75 
MIP-1 6.87±0.44 9.76±0.76  12.56±1.75* 10.57±1.44* 6.85±0.39 7.78±0.65 
MIP-2 11.16±0.42 14.35±1.36 17.22±2.11* 15.77±1.45* 11.69±1.30 12.72±0.82 
E-Selectin 21.92±1.35 26.39±2.88 29.60±4.63 25.02±2.94 18.43±1.93 21.78±2.02 
P-Selectin 140.4±13.9 168.5±15.7 193.9±22.7 154.0±18.8 142.4±11.9 163.5±10.6 
ICAM-1 218.3±12.5 366.0±21.6* 416.3±55.9* 369.7±44.5* 279.9±38.6 259.7±26.7 
VCAM-1 199.0±16.3 220.0±9.7 249.0±32.6 184.2±14.3 199.7±28.6 177.8±13.7 
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5.3.6 Mouse recombinant NEP decreases SP levels in the pancreas, lung and 
plasma. 
We have observed suppression of NEP activity in caerulein-induced AP. 
Therefore, we investigated whether mice would be protected against severe AP by 
treatment of exogenous NEP. Mice received 10 hourly caerulein injections develop 
severe AP and exhibited significantly suppressed NEP activity in the pancreas and 
lungs (Figure 5.6A, 5.6C). Administration of exogenous NEP markedly increase NEP 
activity as well as decreased SP levels in the lung and pancreas (Figure 5.6B, 5.6D). 
Induction of AP did not affect the background plasma NEP activity, but a 10-fold 
increase was observed after mice were treated with exogenous NEP (Figure 5.6E). 
Treatment of mice with exogenous NEP did not completely abolish pathological SP 
levels in the pancreas and plasma. SP levels were still significantly higher in NEP-













Figure 5.6 Effect of exogenous NEP on NEP activity and SP levels. Mice received a 
single dose of normal saline or exogenous NEP (1mg/kg) along with 10 hourly 
caerulein injections. One hour after the last caerulein injection, mice were sacrificed 
and NEP activity and SP ELISA assays were performed as described in Materials and 
Methods. (A) Pancreas NEP activity. (B) Pancreas SP levels. (C) Lung NEP activity. 
(D) Lung SP levels. (E) Plasma NEP activity. (F) Plasma SP levels.  Values are 
means ± SEM; n=10 mice per time point.  *P<0.05 vs. control.  
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5.3.7 Exogenous NEP protects mice against caerulein-induced pancreatic injury 
 
Plasma amylase, as well as MPO activity and water content in the pancreas 
and lungs were strongly augmented after induction of severe AP (Figure 5.7A-5.7E). 
Mouse recombinant NEP (1mg/kg, i.v.), given during the second caerulein injection, 
significantly attenuated AP-induced MPO activity and water content (Figure 5.7B-
5.7E). Exogenous NEP also protected mice against pancreatic injury, as shown by a 
decrease in plasma amylase activity (Figure 5.7A). Histological examination of the 
pancreas confirmed the protective effects, as demonstrated by reduced neutrophil 
infiltration, pancreatic edema and pancreatic necrosis (Figure 5.5G, 5.5H). Notably, 
the therapeutic effect of exogenous NEP correlated with a decrease of SP levels. 
However, a single dose of exogenous NEP treatment did not completely protect mice 
from severe AP, as pancreatic morphology, plasma amylase activity and tissue MPO 









Figure 5.7 Effect of exogenous NEP on plasma amylase activity, tissue MPO activity 
and tissue water content. Mice received a single dose of normal saline or exogenous 
NEP (1mg/kg) along with 10 hourly caerulein injections. One hour after the last 
caerulein injection, mice were sacrificed and amylase activity, MPO activity, and 
water content measurement were performed as described in Materials and Methods. 
(A) Plasma amylase activity. (B) Pancreas MPO activity. (C) Pancreas water content. 
(D) Lung MPO activity. (E) Lung water content. Values are means ± SEM; n=10 
mice per time point.  *P<0.05 vs. control, #P<0.05 vs. caerulein group.  
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5.3.8 Effect of exogenous NEP treatment on pro-inflammatory cytokine, 
chemokine, and adhesion molecule expression 
Mice received 10 hourly caerulein injections (severe AP) showed further 
increase of pro-inflammatory mediator levels in pancreas and lung tissue, when 
compared to mice that received 6 hourly caerulein injections (moderate AP)  (Table 
5.1a, 5.1b, 5.2a, 5.2b). Notably, NEP treatment decreased expression of pro-
inflammatory cytokine (IL-1, IL-6, TNF-), chemokine (MIP-1, MIP-2), and 
adhesion molecule (ICAM-1, VCAM-1, e-selectin, p-selectin) in mice induced with 
severe AP (Table 5.2a, 5.2b). Consistent with MPO and histology results, exogenous 
NEP treatment did not completely protect mice from AP-induced up-regulation of 




Table 5.2. Effect of NEP treatment on expression of cytokine, chemokine and 
adhesion molecules. Mice were randomly given 10 hourly caerulein (Cae10h; 50 
mg/kg, i.p.) injections, and recombinant mouse NEP (1 mg/kg, i.v.) was given during 
the second caerulein injection. Tissue homogenates were subjected to ELISA assay 
and normalized with the DNA content of the homogenate and are expressed as 
picograms per microgram of DNA (n = 10 mice/group). *P<0.05 vs. control, #P<0.05 
vs. caerulein-treated mice. 
(a) In the pancreas 
 Control Cae10h NEP+Cae10h 
IL-1  3.15±0.22 7.93±0.69* 5.37±0.68*
,#
 
IL-6  4.08±0.27  8.30±0.83 * 5.30±0.58
#
 
TNF- 6.62±0.40  19.02±2.08* 8.93±1.48
#
 
MIP-1 2.21±0.29  5.48±0.52* 3.56±0.46*
,#
 
MIP-2 4.11±0.24 8.86±0.64* 6.46±0.53*
,#
 
E-Selectin 8.10±0.57  12.77±0.96* 9.35±0.91
#
 
P-Selectin 26.36±1.99 40.74±2.79* 27.96±2.58
#
 
ICAM-1 33.96±3.11 55.71±5.97 * 41.31±3.14 
VCAM-1 35.63±2.19 57.99±5.80* 42.82±4.86  
 
(b) In the lung 
 Control Cae10h NEP+Cae10h 
IL-1  13.52±1.12 24.75±1.88* 19.03±1.69
#
 
IL-6  11.91±0.53 13.57±2.05  12.35±0.97 
TNF- 10.00±0.94 31.82±3.99* 18.07±1.94
#
 
MIP-1 6.87±0.44 11.71±0.83* 9.11±0.69 
#
 
MIP-2 11.16±0.42 20.88±1.95* 15.37±1.27
#
 
E-Selectin 21.92±1.35 32.98±3.83* 22.57±2.17
#
 
P-Selectin 140.4±13.9 173.5±16.4 135.3±16.4 
ICAM-1 218.3±12.5 473.5±30.8* 316.5±21.9*
,#
 




5.3.9 Exogenous NEP attenuates caerulein-induced NK1R mRNA up-regulation 
in the pancreas 
It was previously reported that disruption of SP-NK1R interaction by 
CP96,345, a selective NK1R antagonist, decreased PPTA and NK1R mRNA 
expression in AP (Lau and Bhatia, 2006). Therefore in this study, we investigated the 
effect of NEP on mRNA expression of PPTA, NK1R and NEP in the pancreas. 
Expectedly, we observed up-regulation of PPTA and NK1R mRNA expression after 
induction of AP (Figure 5.8C-5.8F). However, we found only NK1R expression was 
down-regulated when mice with severe AP received exogenous NEP treatment 
(Figure 5.8F). Inhibition of NEP by phosphoramidon or thiorphan did not affect 
caerulein-induced PPTA/NK1R up-regulation (Figure 5.8C, 5.8E). Interestingly, NEP 
mRNA expression was significantly decreased in moderate AP, but recovered to 













Figure 5.8 Effect of NEP on mRNA expression of NEP, NK1R and PPTA in the 
pancreas. NEP, NK1R and PPTA mRNA expression was determined with real time 
PCR. (A) Inhibition of NEP on NEP mRNA expression. (B) Exogenous NEP on NEP 
mRNA expression. (C) Inhibition of NEP on PPTA mRNA expression. (D) 
Exogenous NEP on PPTA mRNA expression. (E) Inhibition of NEP on NK1R 
expression. (F) Exogenous NEP on NK1R expression. Values are means ± SEM; n=8 





A great deal of preclinical data and some early clinical studies highlighted the 
importance of tachykinin interaction with their receptors for promoting inflammatory 
disorders (Sio et al.; Anichini et al., 1997; Sturiale et al., 1999; Scholzen et al., 2001; 
Tuncer et al., 2004). Thus, identifying the molecular mechanisms that modulate their 
expression is of crucial importance. In chapters 2 and 3, we had explained the 
mechanisms that lead to up-regulation of SP in the pancreatic acinar cells following 
caerulein stimulation (Koh et al., 2010; Koh et al., 2011).  In this chapter, we report 
that caerulein-induced AP suppressed NEP activity in the pancreas and lungs, which 
could contribute to elevated SP levels in the system and promote subsequent 
inflammatory responses. We also report that inhibition of NEP with phosphoramidon 
or thiorphan exacerbated inflammation, and for the first time, treatment of AP-
induced mice with exogenous NEP protected mice against severe AP. 
Our findings identified that NEP was down-regulated by caerulein in mouse 
and isolated mouse pancreatic acinar cells. Time course studies revealed an early and 
rapid decrease of NEP activity after induction of AP, suggesting that NEP might be 
involved in early inflammatory responses. Besides, sustained down-regulation of NEP 
activity throughout the course of AP could contribute to uncontrolled inflammation. 
Interestingly, while pancreatic NEP mRNA expression remained down-regulated 
during moderate AP, its expression during severe AP recovered to a level comparable 
to normal, healthy mice. The effects of longer exposure to caerulein on pancreatic 
NEP expression might suggest activation of recovery mechanisms that help to reverse 
the ongoing inflammation.  
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Although we showed a down-regulation of NEP activity in caerulein-induced 
AP, but the mechanisms that regulate its expression remains unclear. Caerulein might 
directly inactivate transcription factors that regulate NEP mRNA expression. 
However, this did not adequately address why down-regulation of NEP activity 
occurred before down-regulation of NEP mRNA in the pancreatic acinar cells. 
Activation of proteases, necrosis of pancreatic tissue, or generation of reactive oxygen 
species might also indirectly reduce NEP activity in caerulein-induced models 
(Dabrowski et al., 1999). Oxidative stress was shown to inactivate NEP in the lungs 
(Dusser et al., 1989; Roisman and Dusser, 1995). Down-regulation of NEP was also 
observed in inflammatory diseases independent of caerulein stimulation, such as 
inflamed rat intestine and burns (Sio et al.; Hwang et al., 1993). Therefore, the 
regulatory mechanisms of NEP activity in vivo might also involve certain pro-
inflammatory molecules, but it remains to be studied in greater detail. 
SP is a major pro-inflammatory mediator in experimental AP (Maa et al., 
2000b; Bhatia et al., 2003; Noble et al., 2006). NEP is of critical importance in 
modulating SP-induced inflammatory responses, as SP is mainly degraded and 
inactivated by NEP in vivo (Di Maria et al., 1998). In this study, we ascertained the 
role of NEP in two opposite ways: inhibition of NEP with phosphoramidon or 
thiorphan, or administration of exogenous recombinant mouse NEP to increase NEP 
activity. Treatment of mice with exogenous NEP significantly decreased SP levels in 
the mice, occurring in parallel with increased NEP activity. In contrast, NEP 
inhibitor-treated mice showed markedly increased SP levels when compared with 
vehicle-treated mice. Interestingly, exogenous NEP may be reasonably resilient to 
metabolism as markedly elevated activity in the pancreas, lungs and plasma was still 
present after ten hours post treatment. A previous study also suggested that the 
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stability of exogenous NEP was not compromised in the presence of oxidants or 
inflammatory fluids (Solan et al., 1998). On the other hand, the inhibitory effect of 
phosphoramidon and thiorphan decreased over time, showing evidence of drug 
metabolism. In normal healthy mice, NEP inhibitor treatment still decreased basal 
NEP activity at the end of the eight hour treatment protocol. On the contrary, in the 
AP-induced mice groups, pre-treatment of phosphoramidon or thiorphan showed no 
difference in NEP activity levels with mice which did not received the treatment. 
Hence, it appears that the effects of phosphoramidon and thiorphan were neutralized 
at a faster rate in AP-induced mice than normal, healthy mice.  
The present study demonstrates that NEP is protective against the damaging 
effects of caerulein-induced AP by modulating physiological SP levels. Pancreatic 
edema, increased plasma amylase activity, and infiltration of neutrophils into the 
inflamed tissue are well known characteristics of caerulein-induced AP (Sandoval et 
al., 1996; Bhatia et al., 1998; Dabrowski et al., 1999; Grady et al., 2000). In AP, 
plasma amylase level is markedly increased due to this enzyme escaping into the 
blood from damaged pancreatic tissues (Frossard et al., 2008). Exogenous NEP 
protected mice against pancreatic damage and edema, as demonstrated by 
significantly lowered plasma amylase activity and tissue water content. On the 
contrary, mice pre-treated with NEP inhibitors exacerbated pancreatic damage. These 
results agreed with previous reports showing the protective role of NEP in diet-
induced hemorrhagic pancreatitis in mice (Maa et al., 2000b). Our findings were also 
in line with previous reports showing potentiated pancreatitis when animals were 
challenged with exogenous SP. Exogenous SP elevated pancreatic microvascular 
permeability and interstitial space in caerulein-treated mice, which contribute to 
pancreatic microcirculatory dysfunction (Ito et al., 2007). Exogenous SP also 
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increased caerulein stimulated amylase output (Katoh et al., 1984). Despite this, the 
effects of exogenous SP administration on cytokine response in AP-induced animals 
remain to be explored in detail.   
A major feature of AP is the infiltration of neutrophils into the pancreas. 
Induction of AP significantly increased MPO activity in the pancreas, indicating 
massive neutrophil infiltration. In AP-induced mice, MPO activity was abolished by 
exogenous NEP treatment but further increased by NEP inhibitor treatment. Various 
molecules are responsible for recruitment of inflammatory cells and propagation of 
inflammation. Clinically, the presence of endotoxins is linked to more severe cases of 
AP (Pierrakakis et al., 1990). Exogenous administration of endotoxins also strongly 
propagated inflammation and caused a much severe form of hemorrhagic AP in mice 
(Ding et al., 2003). However, the absence of detectable endotoxins in the plasma 
precludes its role as a pro-inflammatory mediator in our model of AP (Guice et al., 
1991). Despite this, a shift in the balance towards up-regulation of pro-inflammatory 
mediators, which include cytokines (IL-1, IL-6 and TNF-), chemokines (MIP-1, 
MIP-2) and adhesion molecules (ICAM-1, VCAM-1, E-selectin, P-selectin) were 
responsible to propagate inflammation in caerulein-induced AP (Tsai et al.; Lau and 
Bhatia, 2006; Sun and Bhatia, 2007). In our study, a significant reduction of pro-
inflammatory mediator expression was observed in NEP treated mice compared with 
mice without treatment. SP is able to up-regulate these mediators in leukocytes and 
pancreatic acinar cells mainly via activation of nuclear factor-B (Ramnath et al., 
2008; Sun et al., 2009). Thus, NEP reduces the pro-inflammatory effects of SP, and 
protects mice against AP.  
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Lung injury is a commonly associated with more severe cases of AP (Pastor et 
al., 2003). Uncontrolled inflammation in the pancreas elevates systemic cytokine 
levels and propagates damage to distant organs, causing SIRS. In our model of 
caerulein-induced AP, the lungs showed similar inflammatory responses with the 
pancreas, which were protected by exogenous NEP. Notably, pre-treatment of NEP 
inhibitors did not aggravate inflammation in the lung following moderate AP, despite 
an increase in lung SP levels. It is possible that in our model of moderate AP, 
inflammatory responses in the lungs is still in an early stage and the effects of SP 
were still insignificant. Nonetheless, the exact role of NEP in the lungs after induction 
of AP requires further investigation. 
Diminished degradation of SP, in itself, did not appear to cause inflammation. 
Mice pre-treated with phosphoramidon or thiorphan without induction of AP raised 
systemic SP levels, but did not cause changes in tissue MPO activity, water content 
and histological appearance. These observations suggest that agents other than NEP 
substrates must first initiate pathological conditions, and then SP acts as a molecule to 
promote the progression of inflammation. In our case, caerulein acted as the initiating 
agent to cause AP. On the other hand, slightly increased 
cytokine/chemokine/adhesion molecule levels were observed in the pancreas and lung 
after inhibition of NEP, when compared to untreated controls. This is not surprising 
as previous studies have shown the expression of cytokines and chemokines can be 
directly up-regulated by NK1R activation via a NF-B dependent mechanism 
(Ramnath and Bhatia, 2006; Sun et al., 2007).   
 Previous studies have shown disruption of SP-NK1R interaction by a NK1R 
antagonist, CP96,345, significantly reversed AP-induced PPTA/NK1R mRNA up-
regulation in the pancreas (Lau and Bhatia, 2006). Therefore, it is necessary to test 
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how NEP affects mRNA expression of PPTA and NK1R after induction of AP. We 
found that only NK1R mRNA expression was abolished on NEP treated AP-induced 
mice, while all other treatment groups showed no significant changes when compared 
to their respective vehicle treated controls. Activation of NK1R may contribute, but 
not dictate, the expression of PPTA/NK1R in mice. Furthermore, in our experiments, 
exogenous NEP did not completely abolish physiological SP availability. An in depth 
study of SP on the expression of PPTA/NK1R is necessary to elucidate the 
mechanisms involved.  
Preclinical experiments that involve disruption of SP-NK1R interaction, 
which include NK1R antagonism and blockade of SP release from sensory nerve 
endings, have successfully protected animals against AP. Results in this study 
describe targeting NEP as a novel mechanism to disrupt SP-NK1R interaction during 
AP, chiefly via degradation of SP. Administration of exogenous NEP was previously 
suggested as a safe and feasible method to protect animals against various 
inflammatory disorders (Neely et al., 1996; Solan et al., 1998; Sturiale et al., 1999; 
Kirkwood et al., 2001). Glucocorticoids, such as dexamethasone, are anti-
inflammatory drugs that were found to increase NEP expression, making it a potential 
therapeutic option to target NEP in SP-mediated inflammatory responses (Borson and 
Gruenert, 1991; Lang and Murlas, 1992). One major limitation of our study is that the 
effects of NEP on other NEP substrates, such as bradykinins and amyloid beta, were 
not addressed.  Besides this, SP can also be degraded by angiotensin converting 
enzyme (ACE) (Skidgel and Erdos, 2004). Future work can be done to address the 
role of ACE in SP-mediated responses in AP.  
On the basis of this series of experiments, we have concluded that a high 
persistent level of SP during AP could be contributed by a disruption of NEP activity, 
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leading to a detrimental inflammatory condition that increases and perpetuates 
pancreatic and lung injury. Pharmacological inhibition of the SP-degrading enzyme 
NEP led to increased availability of SP and exacerbated AP. Conversely, treatment of 
mice with exogenous recombinant NEP protects mice against the detrimental effects 
of severe AP. Taken together, it is hoped that the results of these experiments and 
future studies will lead to new approaches for the prevention of inflammatory cascade 
in patients with AP.    
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CHAPTER 6: SUMMARY OF CONTRIBUTIONS AND FUTURE 
DIRECTIONS 
 
6.1 SUMMARY OF CONTRIBUTIONS 
 
 SP-NK1R interaction has been identified as a key mediator of inflammation. 
Interruption of SP-NK1R interaction has shown promising results on managing the 
detrimental effects of experimental AP. On the other hand, the effects of SP-NK1R 
intereaction could be potentiated due to up-regulation of SP and NK1R. Even though 
many studies have reported elevated levels of SP and NK1R in the inflamed site, 
mechanisms that regulate their expression were not clear. Therefore, this study aimed 
to investigate different mechanisms that might lead to up-regulation of SP and its 
receptor, NK1R, in caerulein-induced AP.  
In the first part of the study, we examined about how caerulein modulated 
SP/NK1R expression in isolated mouse pancreatic acinar cells. Our results showed 
that both gene and protein expression of SP/NK1R were induced by caerulein. The 
up-regulation of both ligand and receptor is interesting, as this might contribute to 
markedly increased SP-NK1R interaction during pathological conditions. It is also 
interesting to note that the expression levels of SP/NK1R were induced by 
supramaximal concentrations (10
-7
M) of caerulein, but not at concentrations that 
stimulate physiological responses (10
-10
M). The effects of caerulein were also rapid, 
with a significant up-regulation of SP/NK1R expression within 30-60 minutes, 
suggesting that increased SP/NK1R levels comes in the early stage of AP.  
After confirming the effect of caerulein on SP/NK1R expression in pancreatic 
acinar cells, we proceeded to investigate the mechanisms involved. We first showed 
that caerulein-induced SP up-regulation was mediated through CCKA receptors by 
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using a selective CCKA antagonist. Then, we demonstrated that treatment of 
pancreatic acinar cells with caerulein (10
-7
M) induced the phosphorylation of PKCs 
(PKC and PKC) and MAPKs (ERK and JNK). We also showed that caerulein 
increased NF-B and AP-1 DNA binding activity. By using specific inhibitors of 
these secondary messengers, we found that caerulein-induced SP/NK1R up-regulation 
was mediated through a PKC-MAPK-NF-B/AP-1 dependent pathway. It is hoped 
that this finding could provide a hint on the regulation of SP/NK1R in other cell types.  
In addition to caerulein-mediated responses, this thesis also explored other 
mechanisms that might regulate SP/NK1R expression in pancreatic acinar cells. In 
chapter 4, we demonstrated that activation of NK1R induced up-regulation of both SP 
and NK1R. By using specific inhibitors, we found that SP-induced up-regulation of 
SP/NK1R involved PKCs, MAPKs and NF-B, which is similar to caerulein-
mediated responses. Our findings also validated a previous study showing SP-induced 
activation of PKC and MAPKs in murine pancreatic acinar cells (Ramnath et al., 
2007; Ramnath et al., 2008). Not surprisingly, we also found that caerulein-induced 
SP/NK1R up-regulation is independent of NK1R activation in isolated pancreatic 
acinar cells. This is interesting as it was previously showed that inhibition of NK1R 
ameliorated SP/NK1R expression in animal models of AP (Lau and Bhatia, 2006). 
Therefore, this auto-regulatory mechanism might be triggered only by a sufficiently 
high amount of SP, as happened during an inflammation. The positive feedback 
mechanism of SP/NK1R expression is significant, as this might cause a much higher 
availability of SP and NK1R, leading to a greater SP-NK1R interaction, and finally to 
a greater potentiation of inflammation.  
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In chapter 5, we investigated the role of NEP in caerulein-induced AP model. 
We found that NEP activity was significantly suppressed in both cellular and animal 
model of caerulein-induced AP. Furthermore, treatment of mice with NEP inhibitors 
raised systemic SP levels and worsened inflammation. On the other hand, treatment 
of mice with exogenous NEP offered partial protection against the detrimental effects 
of AP. Administration of exogenous NEP also decreased systemic SP levels. These 
interesting findings showed that elevated SP levels in AP were constituted from 
multiple mechanisms, which include a diminution of degratory mechanisms.  
 In conclusion, we have demonstrated three possible mechanisms that regulate 
SP/NK1R expression in a murine model of caerulein-induced AP (Figure 6.1). Firstly, 
caerulein could directly stimulate CCKA receptors, and caused up-regulation via a 
PKC-MAPK-NF-B dependant mechanism. Secondly, activation of NK1R itself 
could cause up-regulation of SP/NK1R, possibly via similar downstream mechanisms 
with caerulein. Lastly, caerulein might also cause inhibition and down-regulation of 
NEP activity. A diminished NEP activity will then increase SP bioavailability and 





Figure 6.1 Schematic representation of proposed mechanisms that regulate 
SP/NK1R expression. (1) Activation of CCKA receptors increased SP/NK1R 
expression. (2) Activation of NK1R increased SP/NK1R expression. (3) Caerulein 




6.2 FUTURE DIRECTIONS 
 
Understanding the mechanisms that mediate AP is crucial for the discovery 
and development of more effective treatment strategies. Currently, the focus of drug 
development is on the discovery of new NK1R antagonists. The findings of this thesis 
provided an alternate perspective. As we have shown in chapter 5, regulation of SP 
levels by manipulating NEP activity is one of the mechanisms that cause progression 
of inflammation. Therefore, new therapeutic options that enable regulation of SP 
levels might be a feasible way to manage diseases that involve the SP-NK1R pathway. 
This in turn would help to improve management of inflammatory diseases and 
improve treatment efficacy.   
The research on SP/NK1R expression is still in its early stage. Therefore, 
several key aspects are recommended for future work: 
1. As the neurons are considered as a major source of SP, it is crucial to understand 
how SP/NK1R expression is regulated in neuronal cells.  
2. As angiotensin converting enzyme (ACE) was also shown to be involved in SP 
degradation, the role of ACE in AP could be investigated.  
3. Elucidate the importance and role of SP derived from pancreatic acinar cells in vivo.  
4. Further elucidate possible mechanisms that regulate SP/NK1R expression in 
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